Publication Title
DOI
Year
HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia. https://doi.org/10.1111/bjh.13763 2015
A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. https://doi.org/10.1038/leu.2014.302 2015
Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia https://doi.org/10.3892/ol.2016.5163 2016
Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia. https://doi.org/10.1158/1541-7786.MCR-15-0474 2016
Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD). https://doi.org/10.1016/j.bbamcr.2013.11.022 2014
Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line. https://doi.org/10.1016/j.leukres.2018.09.009 2018
Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia https://doi.org/10.3109/10428194.2012.678004 2012
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. https://doi.org/10.1038/leu.2008.370 2009
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47. https://doi.org/10.1186/s12943-018-0768-2 2018
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. https://doi.org/10.1182/blood-2009-10-248245 2010
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia. https://doi.org/10.1186/s13046-019-1208-x 2019
Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway. https://doi.org/10.1002/jcb.27882 2018
MicroRNA 181a influences the expression of HMGB1 and CD4 in acute Leukemias. https://doi.org/1791-7530 (Electronic) 2013
microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1. https://doi.org/10.1016/j.leukres.2015.01.010 2015
miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20. https://doi.org/10.18632/oncotarget.12018 2016
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. https://doi.org/10.1182/blood-2008-12-191619 2009
MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia. https://doi.org/10.1038/srep31894 2016
miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia. https://doi.org/10.1016/j.leukres.2015.11.016 2015
Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. https://doi.org/10.1111/cas.12766 2015
Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia. https://doi.org/10.1016/j.prp.2019.152494 2019
Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells. https://doi.org/10.17305/bjbms.2017.2457 2018
Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN. https://doi.org/10.1016/j.bbrc.2014.10.107 2014
The Effect of Prednisolone on miR 15a and miR16-1 Expression Levels and Apoptosis in Acute Lymphoblastic Leukemia Cell Line: CCRF-CEM. https://doi.org/10.1055/s-0042-108640 2016
Time-and Concentration-Dependent Effects of Resveratrol on miR 15a and miR16-1 Expression and Apoptosis in the CCRF-CEM Acute Lymphoblastic Leukemia Cell Line. https://doi.org/2476-762X (Electronic) 2015
Circular RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation and metastasis through targeting miR-448 https://doi.org/10.18632/oncotarget.22162 2017
Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP) https://doi.org/10.1007/s13277-014-3021-7 2015
Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma https://doi.org/10.3892/etm.2017.5649 2018
Identification of Differentially Expressed MicroRNAs in Osteosarcoma https://doi.org/10.1155/2011/732690 2011
Identification of Differentially Expressed MicroRNAs in Osteosarcoma https://doi.org/10.1155/2011/732690 2011
LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma https://doi.org/10.26355/eurrev_201910_19269 2019
Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway https://doi.org/10.1016/j.jbo.2019.100228 2019
Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b https://doi.org/10.3727/096504017X14920318811721 2018
MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A https://doi.org/10.18632/oncotarget.10752 2016
MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93 https://doi.org/10.1007/s13402-011-0059-z 2012
MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy https://doi.org/10.1038/s41598-017-00405-3 2017
MicroRNA-29b sensitizes osteosarcoma cells to doxorubicin by targeting matrix metalloproteinase 9 (MMP-9) in osteosarcoma https://doi.org/10.26355/eurrev_201902_17100 2019
MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4 https://doi.org/10.1159/000369661 2014
MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3 https://doi.org/10.3727/096504017X15021536183535 2018
microRNA-625 targets Yes-associated protein 1 to suppress cell proliferation and invasion of osteosarcoma https://doi.org/10.3892/mmr.2017.8079 2018
MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1 https://doi.org/10.3892/etm.2018.7029 2019
MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma https://doi.org/10.3892/or.2016.4718 2016
MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway https://doi.org/10.2147/OTT.S208263 2019
miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of ?-catenin https://doi.org/10.3892/ol.2018.9768 2019
SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression https://doi.org/10.1016/j.bbrc.2019.08.019 2019
MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR https://doi.org/10.1177/1533034615601281 2016
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2 https://doi.org/10.1038/s41598-017-14088-3 2017
The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma https://doi.org/10.1371/journal.pone.0102621 2014
miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway https://doi.org/10.1016/j.bbrc.2017.02.045 2017
miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2 https://doi.org/10.3892/ol.2018.9032 2018
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 https://doi.org/10.1038/onc.2016.194 2017
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells https://doi.org/10.1186/s13046-019-1491-6 2019
miRNA-1284, a regulator of HMGB1, inhibits cell proliferation and migration in osteosarcoma https://doi.org/10.1042/BSR20171675 2018
The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma https://doi.org/10.1038/cddis.2016.468 2017
The effects of TRAF6 on proliferation, apoptosis and invasion in osteosarcoma are regulated by miR-124 https://doi.org/10.3892/ijmm.2018.3458 2018
miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2 https://doi.org/10.1159/000487973 2018
miR-181c associates with tumor relapse of high grade osteosarcoma https://doi.org/10.18632/oncotarget.3539 2015
MiRNA-98-5p inhibits the progression of osteosarcoma by regulating cell cycle via targeting CDC25A expression https://doi.org/10.26355/eurrev_201911_19542 2019
Tumor-suppressing effects of miR-429 on human osteosarcoma https://doi.org/10.1007/s12013-014-9885-8 2014
miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1 https://doi.org/10.3892/ol.2018.8939 2018
Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma https://doi.org/10.1016/j.bbrc.2019.01.139 2019
Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/?-catenin signaling pathway https://doi.org/10.1042/BSR20182366 2019
Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro https://doi.org/10.1007/s13277-015-3801-8 2016
LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway https://doi.org/10.1016/j.biopha.2017.11.014 2018
IL-1?-mediated NF-?B signaling augments the osteosarcoma cell growth through modulating miR-376c/TGFA axis https://doi.org/10.1691/ph.2017.6888 2017
Long non-coding RNA CCAT2 acts as an oncogene in osteosarcoma through regulation of miR-200b/VEGF https://doi.org/10.1080/21691401.2019.1640229 2019
Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells https://doi.org/10.1002/jcb.28360 2019
MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1 https://doi.org/10.1007/s11010-014-2281-2 2015
microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN https://doi.org/10.1186/s11658-019-0173-x 2019
Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway https://doi.org/10.1159/000487567 2018
Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway https://doi.org/10.1042/BSR20171615 2018
Upregulation Of circMMP9 Promotes Osteosarcoma Progression Via Targeting miR-1265/CHI3L1 Axis https://doi.org/10.2147/CMAR.S226264 2019
miR-188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma https://doi.org/10.3892/mmr.2018.8997 2018
lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346 https://doi.org/10.2147/OTT.S160963 2018
RNA binding protein HuR promotes osteosarcoma cell progression via suppressing the miR-142-3p/HMGA1 axis https://doi.org/10.3892/ol.2018.8855 2018
Upregulated microRNA-301a in osteosarcoma promotes tumor progression by targeting CDC14A https://doi.org/10.4238/gmr.15027807 2016
miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met https://doi.org/10.1111/cpr.12187 2015
MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-?2 https://doi.org/10.1371/journal.pone.0119225 2015
miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells https://doi.org/10.1155/2016/7068986 2016
miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control https://doi.org/10.3892/ijo.2012.1717 2013
Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells https://doi.org/10.3390/cancers11111812 2019
MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression https://doi.org/10.1038/mt.2011.53 2011
Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas https://doi.org/10.1038/bjc.2017.174 2017
Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238 https://doi.org/10.1002/jcb.28134 2018
Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E https://doi.org/10.1016/j.biochi.2019.04.017 2019
MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1 https://doi.org/10.3892/ol.2018.8268 2018
MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1 https://doi.org/10.3892/ol.2018.8268 2018
MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3 https://doi.org/10.3892/ijo.2018.4483 2018
Pivotal role of microRNA-9 in osteosarcoma tumorigenesis and tumor progression https://doi.org/10.4238/gmr.15017318 2016
MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/?-catenin pathway https://doi.org/10.3892/ol.2015.4073 2016
MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3 https://doi.org/10.26355/eurrev_201808_15711 2018
The circular RNA circ-ITCH acts as a tumour suppressor in osteosarcoma via regulating miR-22 https://doi.org/10.1080/21691401.2019.1649273 2019
MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression https://doi.org/10.1080/15384047.2019.1683331 2019
MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/?-catenin signaling pathway via targeting the STAT3 gene https://doi.org/10.26355/eurrev_201902_16985 2019
MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt https://doi.org/10.1016/j.gene.2017.12.028 2018
MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells https://doi.org/10.2147/OTT.S95204 2016
MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11 https://doi.org/10.3892/ol.2018.8239 2018
Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3 https://doi.org/10.1016/j.bbrc.2017.06.174 2017
LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1 https://doi.org/10.1002/jcp.28026 2019
MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma https://doi.org/10.1371/journal.pone.0109138 2014
miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16 https://doi.org/10.1186/s12935-019-0829-7 2019
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma https://doi.org/10.1159/000430172 2015
MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin ?2 https://doi.org/10.1007/s13277-015-4696-0 2016
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response https://doi.org/10.1002/ijc.25715 2011
In vitro and in vivo studies of antiosteosarcoma activities of formononetin https://doi.org/10.1002/jcp.28349 2019
Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells https://doi.org/10.1002/stem.1618 2014
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples https://doi.org/10.1016/j.bbrc.2009.07.101 2009
Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1? https://doi.org/10.1042/BSR20170080 2019
The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis https://doi.org/10.1080/21691401.2019.1669622 2019
MiR-23a functions as a tumor suppressor in osteosarcoma https://doi.org/10.1159/000366353 2014
Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro https://doi.org/10.1177/1010428317697556 2017
Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells https://doi.org/10.3390/cancers11122019 2019
DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc https://doi.org/10.7150/ijbs.19476 2017
MiR-329 suppresses osteosarcoma development by downregulating Rab10 https://doi.org/10.1002/1873-3468.12337 2016
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma https://doi.org/10.1002/cam4.2320 2019
NAIF1 suppresses osteosarcoma progression and is regulated by miR-128 https://doi.org/10.1002/cbf.3365 2018
Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration https://doi.org/10.1002/jcb.25879 2017
MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1 https://doi.org/10.1002/jcb.26024 2017
Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/?-catenin signaling pathway https://doi.org/10.1002/jcb.27580 2018
miR-421 promotes apoptosis and suppresses metastasis of osteosarcoma cells via targeting LTBP2 https://doi.org/10.1002/jcb.28144 2019
Dysregulated circRNA_100876 suppresses proliferation of osteosarcoma cancer cells by targeting microRNA-136 https://doi.org/10.1002/jcb.28837 2019
Dysregulated circRNA_100876 suppresses proliferation of osteosarcoma cancer cells by targeting microRNA-136 https://doi.org/10.1002/jcb.28837 2019
Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells https://doi.org/10.1002/jcp.27435 2019
Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1 https://doi.org/10.1002/jcp.27572 2019
Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway https://doi.org/10.1002/mc.22593 2017
Long noncoding RNA NEAT1 regulates the development of osteosarcoma through sponging miR-34a-5p to mediate HOXA13 expression as a competitive endogenous RNA https://doi.org/10.1002/mgg3.673 2019
LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma https://doi.org/10.1007/s00280-019-03822-5 2019
A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy 2017 2017
Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR https://doi.org/10.1007/s11596-014-1369-y 2014
MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61 https://doi.org/10.1007/s13277-013-1146-8 2014
MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1 https://doi.org/10.1007/s13277-014-2031-9 2014
Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL. https://doi.org/10.1016/j.leukres.2012.02.013 2012
Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia. https://doi.org/10.1371/journal.pone.0111777 2014
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. https://doi.org/10.1182/blood-2010-12-326629 2011
Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. https://doi.org/10.1038/leu.2014.133 2014
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. https://doi.org/10.1084/jem.20122516 2013
TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. https://doi.org/10.1182/blood-2009-02-206706 2010
Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. https://doi.org/10.1038/leu.2017.80 2017
The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by down-regulating ERK BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression https://doi.org/10.1038/leu.2017.82 2017
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukem https://doi.org/10.1186/1756-8722-6-21 2013
8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia https://doi.org/10.1002/jcp.28294 2019
Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. https://doi.org/10.1038/onc.2011.248 2012
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia https://doi.org/10.1073/pnas.1310144110 2013
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells https://doi.org/10.1111/jcmm.12617 2015
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication https://doi.org/10.1158/0008-5472.CAN-13-1733 2014
A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia https://doi.org/10.1186/s12885-018-4097-z 2018
microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R https://doi.org/10.2147/OTT.S192137 2019
miR-1271-5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2 https://doi.org/10.3892/mmr.2018.9680 2019
Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis https://doi.org/10.1159/000495387 2018
MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion https://doi.org/10.3892/or.2017.6142 2018
MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/?-catenin pathway https://doi.org/10.3892/ijo.2019.4735 2019
Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells https://doi.org/10.1002/cam4.1677 2018
Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma https://doi.org/10.1002/jcb.26294 2018
lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1? in osteosarcoma https://doi.org/10.1002/jcb.27941 2019
miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2 https://doi.org/10.1007/s11010-014-2195-z 2014
miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism https://doi.org/10.1007/s11010-015-2344-z 2015
miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2) https://doi.org/10.1007/s13277-014-2822-z 2015
MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT? https://doi.org/10.1016/j.abb.2013.04.001 2013
Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma https://doi.org/10.1016/j.bbrc.2017.06.024 2017
miR-19 promotes osteosarcoma progression by targeting SOCS6 https://doi.org/10.1016/j.bbrc.2017.10.002 2018
Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge https://doi.org/10.1016/j.bbrc.2017.12.050 2018
MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1 https://doi.org/10.1016/j.bbrc.2018.04.124 2018
The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma https://doi.org/10.1016/j.biopha.2015.02.014 2015
MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1 https://doi.org/10.1038/boneres.2015.33 2015
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells https://doi.org/10.1038/onc.2009.274 2009
miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2 https://doi.org/10.1038/s41598-017-18739-3 2018
MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma https://doi.org/10.1038/srep34238 2016
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells https://doi.org/10.1186/1476-4598-9-96 2010
MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion https://doi.org/10.1186/s13000-019-0889-y 2019
Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b https://doi.org/10.12659/MSM.912703 2019
LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p https://doi.org/10.18632/aging.102427 2019
MicroRNA-492 overexpression exerts suppressive effects on the progression of osteosarcoma by targeting PAK7 https://doi.org/10.3892/ijmm.2017.3046 2017
Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients https://doi.org/10.3892/or.2014.2989 2014
MicroRNA-708-5p affects proliferation and invasion of osteosarcoma cells by targeting URGCP https://doi.org/10.3892/etm.2019.7171 2019
MicroRNA-744 promotes carcinogenesis in osteosarcoma through targeting LATS2 https://doi.org/10.3892/ol.2019.10530 2019
MicroRNA-183 suppresses the vitality, invasion and migration of human osteosarcoma cells by targeting metastasis-associated protein 1 https://doi.org/10.3892/etm.2018.6068 2018
miRNA-30c can be used as a target in the diagnosis and treatment of osteosarcoma https://doi.org/10.2147/OTT.S181177 2018
Upregulated miRNA-1236-3p in osteosarcoma inhibits cell proliferation and induces apoptosis via targeting KLF8 https://doi.org/10.26355/eurrev_201907_18418 2019
MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells https://doi.org/10.3892/ol.2017.6441 2017
Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma https://doi.org/10.2147/CMAR.S214569 2019
miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1 https://doi.org/10.3233/CBM-181527 2018
Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells https://doi.org/10.1007/s12031-017-1017-7 2018
Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis https://doi.org/10.1016/j.biopha.2018.08.020 2018
LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101 https://doi.org/10.1016/j.ejphar.2018.11.028 2019
Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways https://doi.org/10.1016/j.exer.2014.02.017 2014
MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma https://doi.org/10.1038/eye.2016.189 2016
miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma https://doi.org/10.1101/gad.17027411 2011
Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells https://doi.org/10.1167/iovs.09-3520 2009
-EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression https://doi.org/10.1371/journal.pone.0114800 2014
-EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression https://doi.org/10.1371/journal.pone.0114800 2014
Downregulation of microRNA182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation https://doi.org/10.3892/ijo.2018.4587 2018
MicroRNA98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/kRas/Raf/MEK/ERK signaling pathway https://doi.org/10.3892/ijo.2019.4689 2019
Evaluation of SD-208, a TGF-beta-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma https://doi.org/ 2013
MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway https://doi.org/10.1002/cbin.10678 2016
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells https://doi.org/10.1182/blood-2006-09-045104 2007
Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma https://doi.org/10.3233/cbm-170721 2018
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression https://doi.org/10.1016/j.biopha.2016.05.003 2016
Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation https://doi.org/10.1371/journal.pone.0138366 2015
Blocking the maturation of OncomiRNAs using pri-miRNA-17 approximately 92 aptamer in retinoblastoma https://doi.org/10.1089/nat.2014.0507 2015
Effects of miR-26a on the expression of Beclin 1 in retinoblastoma cells https://doi.org/10.4238/gmr.15028193 2016
Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma https://doi.org/10.1016/j.biopha.2018.10.096 2019
Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma https://doi.org/10.3727/096504017x14953948675403 2018
MicroRNA382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNFmediated PI3K/AKT signalling pathway https://doi.org/10.3892/mmr.2017.7396 2017
MicroRNA758 inhibits malignant progression of retinoblastoma by directly targeting PAX6 https://doi.org/10.3892/or.2018.6563 2018
MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/beta-catenin pathway https://doi.org/10.3233/cbm-182315 2019
MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2 https://doi.org/10.3892/or.2014.3167 2014
MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway https://doi.org/10.1042/bsr20180776 2018
MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells https://doi.org/10.1016/j.biopha.2018.06.038 2018
miR-29a inhibits human retinoblastoma progression by targeting STAT3 https://doi.org/10.3892/or.2017.6144 2018
MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell https://doi.org/10.4161/auto.27418 2014
Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells https://doi.org/10.3109/02713683.2011.647224 2012
Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells https://doi.org/10.3109/02713683.2011.647224 2012
miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3 https://doi.org/10.3892/or.2016.4999 2016
MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma https://doi.org/10.1002/iub.1710 2018
Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p https://doi.org/10.1002/iub.2064 2019
Interleukin-1?/nuclear factor-?B signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis https://doi.org/10.1002/jcb.27477 2019
MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1 https://doi.org/10.1002/jcb.27822 2019
MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2 https://doi.org/10.1002/jcb.29438 2020
miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells https://doi.org/10.1007/s11010-013-1786-4 2013
LncRNA KCNQ1OT1 acting as a ceRNA for miR-4458 enhances osteosarcoma progression by regulating CCND2 expression https://doi.org/10.1007/s11626-019-00386-9 2019
miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells https://doi.org/10.1007/s13277-014-1637-2 2014
miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1 https://doi.org/10.1007/s13277-015-3120-0 2015
MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1 https://doi.org/10.1016/j.bbrc.2018.06.121 2018
LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis https://doi.org/10.1016/j.bbrc.2018.07.137 2018
The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect https://doi.org/10.1016/j.bbrc.2018.08.035 2018
miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor https://doi.org/10.1016/j.biopha.2015.04.012 2015
miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells https://doi.org/10.1016/j.biopha.2016.09.108 2016
RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis https://doi.org/10.1016/j.biopha.2017.08.068 2017
miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9 https://doi.org/10.1016/j.biopha.2018.06.124 2018
LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis https://doi.org/10.1016/j.biopha.2019.108798 2019
MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-?1 https://doi.org/10.1016/j.gene.2016.03.021 2016
MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9 https://doi.org/10.1016/j.gene.2018.08.078 2018
Role of microRNA-503 in the suppression of osteosarcoma cell proliferation and migration via modulation of fibroblast growth factor 2 https://doi.org/10.3892/mmr.2015.4399 2015
Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells https://doi.org/10.3892/ol.2018.9739 2019
MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4 https://doi.org/10.1016/j.jbo.2016.02.002 2016
miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting ?B-crystallin https://doi.org/10.1016/j.ymthe.2017.05.018 2017
miR-218 expression in osteosarcoma tissues and its effect on cell growth in osteosarcoma cells https://doi.org/10.1016/S1995-7645(14)60176-0 2014
MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma https://doi.org/10.1038/srep41456 2017
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma https://doi.org/10.1074/jbc.M112.445890 2013
MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4 https://doi.org/10.1080/21691401.2018.1464459 2018
Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP https://doi.org/10.1080/21691401.2019.1601099 2019
The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells https://doi.org/10.1080/21691401.2019.1640714 2019
MicroRNA-125a Regulates Cell Proliferation Via Directly Targeting E2F2 in Osteosarcoma https://doi.org/10.1159/000481560 2017
miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1 https://doi.org/10.1159/000495085 2018
MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2 https://doi.org/10.1177/1010428317705761 2017
MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma https://doi.org/10.1177/1533034615618849 2016
MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7 https://doi.org/10.1371/journal.pone.0175553 2017
MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2 https://doi.org/10.18632/oncotarget.3305 2015
miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1 https://doi.org/10.18632/oncotarget.9948 2016
TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma https://doi.org/10.2147/OTT.S163163 2018
miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma https://doi.org/10.2147/OTT.S171304 2018
miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib https://doi.org/10.2147/OTT.S215145 2019
MiR-361 inhibits osteosarcoma cell lines invasion and proliferation by targeting FKBP14 https://doi.org/10.26355/eurrev_201801_14103 2018
MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways https://doi.org/10.26355/eurrev_201809_15806 2018
MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5 https://doi.org/10.26355/eurrev_201810_16140 2018
MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1 https://doi.org/10.26355/eurrev_201811_16253 2018
MicroRNA-1247 inhibits the viability and metastasis of osteosarcoma cells via targeting NRP1 and mediating Wnt/?-catenin pathway https://doi.org/10.26355/eurrev_201909_18831 2019
MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2 https://doi.org/10.26355/eurrev_201910_19270 2019
MiR-409-3p Inhibits Cell Proliferation and Invasion of Osteosarcoma by Targeting Zinc-Finger E-Box-Binding Homeobox-1 https://doi.org/10.3389/fphar.2019.00137 2019
MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS https://doi.org/10.3892/etm.2016.3085 2016
MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor https://doi.org/10.3892/etm.2017.4648 2017
MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3 https://doi.org/10.3892/etm.2017.5356 2018
microRNA-25 promotes osteosarcoma cell proliferation by targeting the cell-cycle inhibitor p27 https://doi.org/10.3892/mmr.2014.2260 2014
MicroRNA-214 regulates osteosarcoma survival and growth by directly targeting phosphatase and tensin homolog https://doi.org/10.3892/mmr.2014.2616 2014
The downregulation of miR-125a-5p functions as a tumor suppressor by directly targeting MMP-11 in osteosarcoma https://doi.org/10.3892/mmr.2016.5141 2016
MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma https://doi.org/10.3892/ol.2018.8294 2018
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma https://doi.org/10.1016/j.bone.2011.10.012 2012
A Single Nucleotide Polymorphism (rs1056629) in 3'-UTR of MMP-9 is Responsible for a Decreased Risk of Metastatic Osteosarcoma by Compromising its Interaction with microRNA-491-5p https://doi.org/10.1159/000443084 2016
CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d https://doi.org/10.18632/oncotarget.1998 2014
MicroRNA-643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma https://doi.org/10.3892/mmr.2017.7273 2017
MicroRNA-330-5p inhibits osteosarcoma cell growth and invasion by targeting the proto-oncogene survivin https://doi.org/10.3892/mmr.2019.10447 2019
Knockdown of Long Non-Coding RNA NEAT1 Inhibits Proliferation and Invasion and Induces Apoptosis of Osteosarcoma by Inhibiting miR-194 Expression https://doi.org/10.3349/ymj.2017.58.6.1092 2017
Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma https://doi.org/10.3892/ijo.2017.4187 2018
Knockdown of lncRNA HOXA-AS2 Inhibits Viability, Migration and Invasion of Osteosarcoma Cells by miR-124-3p/E2F3 https://doi.org/10.2147/OTT.S220072 2019
miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells https://doi.org/10.3892/or.2017.6150 2018
miR-17-5p promotes the growth of osteosarcoma in a BRCC2-dependent mechanism https://doi.org/10.3892/or.2016.4542 2016
LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p https://doi.org/10.18632/aging.102448 2019
MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/?-catenin signaling pathway https://doi.org/10.3892/or.2017.6129 2018
Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells https://doi.org/10.1111/cas.13201 2017
Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells https://doi.org/10.18632/oncotarget.19727 2017
Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells https://doi.org/10.1080/15384101.2018.1489174 2018
Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma https://doi.org/10.1186/s12943-018-0837-6 2018
MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether ? go-go 1 expression https://doi.org/10.7150/ijms.5528 2013
Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro https://doi.org/10.3892/ol.2018.8643 2018
Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression https://doi.org/10.1186/s12943-019-1007-1 2019
Decreased Expression of miR-548c-3p in Osteosarcoma Contributes to Cell Proliferation Via Targeting ITGAV https://doi.org/10.1089/cbr.2016.1995 2016
MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1 https://doi.org/10.1007/s13277-015-4389-8 2016
Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262 https://doi.org/10.1007/s13277-015-4530-8 2017
Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma https://doi.org/10.1007/s13277-016-5417-z 2019
Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma https://doi.org/OS/-/hsa-mir-192-5p/MG-63/10.1007/s13277-016-5417-z 2019
The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma https://doi.org/10.1007/s13277-016-5386-2 2019
MicroRNA-497-5p Suppresses Tumor Cell Growth of Osteosarcoma by Targeting ADP Ribosylation Factor-Like Protein 2 https://doi.org/10.1089/cbr.2017.2268 2018
MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma https://doi.org/10.1007/s13277-016-5379-1 2019
MicroRNA-520b Suppresses Proliferation, Migration, and Invasion of Spinal Osteosarcoma Cells via Downregulation of Frizzled-8 https://doi.org/10.3727/096504017X14873430389189 2018
Upregulation of microRNA-25-3p inhibits proliferation, migration and invasion of osteosarcoma cells in vitro by directly targeting SOX4 https://doi.org/10.3892/mmr.2017.7103 2019
MicroRNA-935 inhibits proliferation and invasion of osteosarcoma cells by directly targeting High mobility group box 1 https://doi.org/10.3727/096504018X15189093975640 2016
miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor https://doi.org/10.3233/CBM-170906 2016
MiR-378 promotes the cell proliferation of osteosarcoma through down-regulating the expression of Kruppel-like factor 9 https://doi.org/10.1139/bcb-2017-0186 2016
Knockdown of Long Noncoding RNA TUG1 Inhibits the Proliferation and Cellular Invasion of Osteosarcoma Cells by Sponging miR-153 https://doi.org/10.3727/096504017X14908298412505 2018
Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1 https://doi.org/10.1016/j.biopha.2018.08.025 2019
MicroRNA-103 Promotes Proliferation and Inhibits Apoptosis in Spinal Osteosarcoma Cells by Targeting p57 https://doi.org/10.3727/096504017X15144741233346 2019
Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p/YB-1 axis https://doi.org/10.1002/cbf.3452 2019
The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression https://doi.org/10.1074/jbc.RA118.005778 2017
The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression https://doi.org/10.1074/jbc.RA118.005778 2017
miR-363-3p Inhibits Osteosarcoma Cell Proliferation and Invasion via Targeting SOX4 https://doi.org/10.3727/096504018X15190861873459 2018
miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma https://doi.org/10.1089/cbr.2018.2761 2019
miR-9 is a tumor suppressor in pediatric AML with t(8;21) https://doi.org/10.1038/leu.2013.357 2014
Knockdown of ZFAS1 suppresses the progression of acute myeloid leukemia by regulating microRNA-150/Sp1 and microRNA-150/Myb pathways https://doi.org/10.1016/j.ejphar.2018.11.036 2019
A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells https://doi.org/10.18632/oncotarget.19192 2017
miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications https://doi.org/10.1186/s40164-016-0033-6 2016
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia https://doi.org/10.1038/onc.2011.62 2011
Lenalidomide-mediated enhanced translation of C/EBP?-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia https://doi.org/10.1182/blood-2012-05-428573 2013
MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia https://doi.org/10.1016/j.leukres.2011.06.010 2011
The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia https://doi.org/10.1038/cdd.2013.133 2014
miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways https://doi.org/10.1038/cddis.2016.256 2016
Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation https://doi.org/10.1038/leu.2009.246 2010
miR-139-5p controls translation in myeloid leukemia through EIF4G2 https://doi.org/10.1038/onc.2015.247 2016
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway https://doi.org/10.1126/scisignal.2004762 2014
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 https://doi.org/10.1182/blood-2008-07-170589 2009
The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression https://doi.org/10.1186/s13046-016-0283-5 2016
Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia https://doi.org/10.1371/journal.pone.0047717 2012
Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia https://doi.org/10.1371/journal.pone.0047717 2012
MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia https://doi.org/10.2147/OTT.S45376 2013
miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia https://doi.org/10.3727/096504016X14829256525028 2017
Overexpression of miR-21 is involved in acute monocytic leukemia-associated angiogenesis by targeting IL-12 https://doi.org/10.3892/mmr.2018.9357 2018
Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9 https://doi.org/10.1002/jcp.26621 2018
Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p https://doi.org/10.1016/j.biopha.2019.108627 2019
Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation https://doi.org/10.1016/j.cellsig.2016.04.002 2016
MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9 https://doi.org/10.1016/j.febslet.2015.01.030 2015
LncRNA HOTAIR/miR-613/c-met axis modulated epithelial-mesenchymal transition of retinoblastoma cells https://doi.org/10.1111/jcmm.13796 2018
MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5 https://doi.org/10.1177/1010428317691674 2017
miR34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGEA/p53 signaling https://doi.org/10.3892/ijo.2018.4613 2019
Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells https://doi.org/10.1007/s11596-012-1004-8 2012
Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a https://doi.org/10.4149/neo_2013_033 2013
Inhibition of microRNA492 attenuates cell proliferation and invasion in retinoblastoma via directly targeting LATS2 https://doi.org/10.3892/mmr.2018.9784 2019
miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1 https://doi.org/10.1007/s00381-017-3622-8 2018
Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p https://doi.org/10.1016/j.biopha.2017.01.004 2017
The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling https://doi.org/10.1016/j.biopha.2018.06.099 2018
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6 https://doi.org/10.1016/j.febslet.2013.04.029 2013
ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/beta-catenin pathway in retinoblastoma https://doi.org/10.1016/j.ijbiomac.2019.01.157 2019
Silence of lncRNA ANRIL represses cell growth and promotes apoptosis in retinoblastoma cells through regulating miR-99a and c-Myc https://doi.org/10.1080/21691401.2019.1623229 2019
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6 https://doi.org/10.1111/febs.12659 2014
Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma https://doi.org/10.1247/csf.18033 2019
Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma https://doi.org/10.26355/eurrev_201712_14005 2017
Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells https://doi.org/10.3892/ijo.2011.961 2011
MicroRNA504 targets AEG1 and inhibits cell proliferation and invasion in retinoblastoma https://doi.org/10.3892/mmr.2019.9923 2019
MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1 https://doi.org/10.3892/mmr.2017.6767 2017
Downregulation of microRNA198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN https://doi.org/10.3892/mmr.2018.8979 2018
MicroRNA874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin https://doi.org/10.3892/mmr.2018.9295 2018
Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6 https://doi.org/10.3892/or.2015.3900 2015
miR106b regulates retinoblastoma Y79 cells through Runx3 https://doi.org/10.3892/or.2017.5931 2017
MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways https://doi.org/10.3892/or.2018.6264 2018
MicroRNA448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway https://doi.org/10.3892/or.2018.6302 2018
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia https://doi.org/10.1038/leu.2015.106 2015
MicroRNA-635 inhibits the malignancy of osteosarcoma by inducing apoptosis https://doi.org/10.3892/mmr.2017.7127 2017
MiR-372-3p inhibits the growth and metastasis of osteosarcoma cells by targeting FXYD6 https://doi.org/10.26355/eurrev_201801_14101 2018
miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma https://doi.org/10.12659/MSM.911972 2018
miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma. https://doi.org/10.1016/j.biopha.2017.12.086 2018
MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-? (TGF-?) Signaling Pathway https://doi.org/10.12659/MSM.916939 2019
miR-9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16 https://doi.org/10.3892/ijo.2019.4783 2019
miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma https://doi.org/10.1186/s12935-018-0696-7 2018
MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2 https://doi.org/10.3892/etm.2017.4435 2017
The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206 https://doi.org/10.1111/jcmm.14087 2019
Deregulated WWOX is involved in a negative feedback loop with microRNA-214-3p in osteosarcoma https://doi.org/10.3892/ijmm.2016.2800 2016
Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma https://doi.org/10.1159/000495554 2018
miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9 https://doi.org/10.1007/s13277-014-2588-3 2014
MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2 https://doi.org/10.1007/s13277-015-3290-9 2015
MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb https://doi.org/10.1007/s13277-016-4797-4 2016
miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression https://doi.org/10.1016/j.bbrc.2014.01.061 2014
Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/?-catenin pathway https://doi.org/10.1016/j.bbrc.2017.11.012 2018
MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells https://doi.org/10.1016/j.biopha.2019.108720 2019
Circular RNA circNASP modulates the malignant behaviors in osteosarcoma via miR-1253/FOXF1 pathway https://doi.org/10.1016/j.bbrc.2018.04.131 2018
Long noncoding RNA LINC00858 promotes osteosarcoma through regulating miR-139-CDK14 axis https://doi.org/10.1016/j.bbrc.2018.06.131 2018
SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5 https://doi.org/10.1016/j.bbrc.2019.02.110 2019
IL-1?-induced NF-?B activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1 https://doi.org/10.1016/j.biopha.2017.08.120 2017
MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1 https://doi.org/10.1016/j.bone.2013.05.020 2013
lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition https://doi.org/10.1016/j.canlet.2017.06.009 2017
Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7 https://doi.org/10.1016/j.gene.2017.01.002 2017
miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/?-Catenin Signaling https://doi.org/10.1016/j.omtn.2017.06.008 2017
miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6 https://doi.org/10.1016/j.ymthe.2018.03.009 2018
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14 https://doi.org/10.1038/cddis.2017.499 2017
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma https://doi.org/10.1038/srep11365 2015
Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma https://doi.org/10.1042/BSR20180375 2018
MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma https://doi.org/10.1089/cbr.2017.2394 2019
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia https://doi.org/10.1016/j.ccr.2012.08.028 2012
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia https://doi.org/10.1038/ncomms11452 2016
MicroRNA-638 expression change in osteosarcoma patients via PLD1 and VEGF expression https://doi.org/10.3892/etm.2019.7429 2019
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia https://doi.org/10.1073/pnas.1217519109 2012
Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7. https://doi.org/10.1371/journal.pone.0127682 2015
LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765 https://doi.org/10.1002/jcb.27999 2018
MicroRNA-944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma https://doi.org/10.3892/mmr.2018.9524 2018
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia https://doi.org/10.1101/gad.1856210 2010
miR-137 downregulates c-kit expression in acute myeloid leukemia https://doi.org/10.1016/j.leukres.2017.01.028 2017
Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia https://doi.org/10.18632/oncotarget.11150 2016
MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1 https://doi.org/10.3892/or.2014.3687 2015
MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2 https://doi.org/10.1016/j.lfs.2017.10.010 2017
Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma https://doi.org/10.1007/s13402-016-0288-2 2016
Long non-coding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating miR-4443/NUPR1 axis https://doi.org/10.3727/096504018X15188367859402 2018
MicroRNA-376a inhibits cell proliferation and invasion in osteosarcoma via directly targeting SATB1 https://doi.org/10.3892/mmr.2018.9344 2018
MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a https://doi.org/10.3892/or.2015.4495 2016
Hsa-let-7g promotes osteosarcoma by reducing HOXB1 to activate NF-kB pathway https://doi.org/10.1016/j.biopha.2018.11.026 2019
miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1 https://doi.org/10.1016/j.bbrc.2014.04.140 2014
CircSAMD4A accelerates cell proliferation of osteosarcoma by sponging miR-1244 and regulating MDM2 mRNA expression https://doi.org/10.1016/j.bbrc.2019.05.182 2019
miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2 https://doi.org/10.1089/dna.2015.3121 2016
Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p https://doi.org/10.1002/jcb.26743 2018
MicroRNA-645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM23 nucleoside diphosphate kinase 2 https://doi.org/10.1111/1440-1681.13006 2018
BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway https://doi.org/10.1089/dna.2016.3579 2017
RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs https://doi.org/10.1111/cpr.12508 2018
MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2 https://doi.org/10.1177/1010428317705751 2017
MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2 https://doi.org/10.1186/s13046-016-0348-5 2016
The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression https://doi.org/10.1371/journal.pone.0121175 2015
miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A https://doi.org/10.1371/journal.pone.0132225 2015
MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression https://doi.org/10.18632/aging.101468 2018
Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom https://doi.org/10.18632/aging.102109 2019
Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells https://doi.org/10.18632/oncotarget.16104 2017
Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142 https://doi.org/10.1016/j.biopha.2018.04.146 2018
Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8 https://doi.org/10.1691/ph.2018.8644 2018
MiR-205 functions as a tumor suppressor via targeting TGF-? in osteosarcoma https://doi.org/10.1016/j.yexmp.2015.12.010 2016
Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195 https://doi.org/10.18632/oncotarget.13012 2016
miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma https://doi.org/10.1007/s13277-015-4578-5 2016
LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p https://doi.org/10.1016/j.bbrc.2017.12.047 2018
Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203 https://doi.org/10.18632/oncotarget.23466 2017
MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells https://doi.org/10.3892/mmr.2018.8790 2018
MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 https://doi.org/OS/-/hsa-mir-340/SaOS-2/10.1016/j.bbrc.2013.07.033 2013
miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST https://doi.org/10.1186/1756-9966-33-12 2014
MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1 https://doi.org/10.1007/s13577-016-0148-4 2017
miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/?-catenin signaling pathway https://doi.org/10.1016/j.biocel.2019.04.004 2019
MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1? https://doi.org/10.3727/096504016X14743337535446 2017
Overexpression of miR-20a promotes the progression of osteosarcoma by directly targeting QKI2 https://doi.org/10.3892/ol.2019.10313 2019
The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis https://doi.org/10.1080/15384047.2019.1598766 2019
MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma https://doi.org/10.3892/etm.2017.4947 2017
lncRNA-NEF is downregulated in osteosarcoma and inhibits cancer cell migration and invasion by downregulating miRNA-21 https://doi.org/10.3892/ol.2019.10276 2019
A Novel lncRNA MYOSLID/miR-1286/RAB13 Axis Plays a Critical Role in Osteosarcoma Progression https://doi.org/10.2147/CMAR.S231376 2019
MicroRNA-302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9 https://doi.org/10.3892/mmr.2017.6975 2017
Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1 https://doi.org/10.3892/ol.2016.4827 2016
microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN https://doi.org/10.1016/j.lfs.2018.04.012 2018
Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma https://doi.org/10.1042/CS20150509 2016
Long Noncoding RNA SNHG16 Promotes Cell Proliferation by Sponging MicroRNA-205 and Upregulating ZEB1 Expression in Osteosarcoma https://doi.org/10.1159/000495239 2018
Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin https://doi.org/10.1016/j.ajpath.2012.02.023 2012
MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN https://doi.org/10.3892/ijmm.2015.2352 2015
MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6 https://doi.org/10.1007/s13238-016-0277-2 2016
LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis https://doi.org/10.1016/j.ymthe.2017.06.027 2017
Overexpression of miR-214 promotes the progression of human osteosarcoma by regulating the Wnt/?-catenin signaling pathway https://doi.org/10.3892/mmr.2017.6203 2017
miR-219a-5p represses migration and invasion of osteosarcoma cells via targeting EYA2 https://doi.org/10.1080/21691401.2018.1525391 2018
Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway https://doi.org/10.1002/jcb.26145 2017
CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613 https://doi.org/10.1111/cas.13653 2018
MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells https://doi.org/10.1371/journal.pone.0150026 2016
MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma https://doi.org/10.1186/s12935-018-0612-1 2018
MicroRNA-20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression https://doi.org/10.3892/mmr.2015.4098 2015
MicroRNA-21 is involved in osteosarcoma cell invasion and migration https://doi.org/10.1007/s12032-010-9563-7 2011
MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression https://doi.org/10.18632/oncotarget.17045 2017
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma https://doi.org/10.18632/oncotarget.26284 2018
miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9 https://doi.org/10.7314/apjcp.2013.14.6.3681 2013
Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5 https://doi.org/10.3892/or.2017.5715 2017
MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31 https://doi.org/10.3892/or.2014.3274 2014
Long non-coding RNA MIAT competitively binds miR-150-5p to regulate ZEB1 expression in osteosarcoma https://doi.org/10.3892/ol.2018.9671 2019
miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-?1 signaling pathway https://doi.org/10.3892/ol.2018.9177 2018
MicroRNA-124 acts as a tumor-suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma https://doi.org/10.3892/ol.2018.7994 2018
miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1 https://doi.org/10.1097/CAD.0000000000000614 2018
LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5 https://doi.org/10.1016/j.gene.2019.144093 2019
Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma https://doi.org/10.1371/journal.pone.0055072 2013
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma https://doi.org/10.1016/j.ccr.2008.10.006 2008
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation https://doi.org/10.1172/JCI38075 2009
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development https://doi.org/10.1074/jbc.M109.020511 2009
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas https://doi.org/10.1038/sj.bjc.6605684 2010
MicroRNA-130a inhibits growth and metastasis of osteosarcoma cells by directly targeting ZEB1 https://doi.org/10.3892/mmr.2017.6968 2017
Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma https://doi.org/10.1111/cpr.12308 2017
MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1 https://doi.org/10.3727/096504016X14826089198805 2017
Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma https://doi.org/10.18926/AMO/55857 2018
MicroRNA-885-5p promotes osteosarcoma proliferation and migration by downregulation of cell division cycle protein 73 homolog expression https://doi.org/10.3892/ol.2018.9802 2019
Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B https://doi.org/10.2147/CMAR.S185090 2018
Clinical significance of microRNA-130b in osteosarcoma and in cell growth and invasion. https://doi.org/10.1016/j.apjtm.2015.07.026 2015
MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma https://doi.org/10.3892/mmr.2018.8374 2018
MicroRNA-144 acts as a tumor suppressor by targeting Rho-associated coiled-coil containing protein kinase 1 in osteosarcoma cells https://doi.org/10.3892/mmr.2015.3937 2015
microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R https://doi.org/10.3892/ijo.2014.2571 2014
MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-?B signalling pathway through negatively targeting DNMT3B https://doi.org/10.3892/ijmm.2019.4287 2019
MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma https://doi.org/10.3892/etm.2014.2161 2015
MicroRNA-107 Promotes Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Tropomyosin 1 https://doi.org/10.3727/096504017X14882829077237 2017
miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1 https://doi.org/10.3233/CBM-180013 2019
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells https://doi.org/10.1096/fj.09-150698 2010
MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration https://doi.org/10.1158/0008-5472.CAN-10-2074 2010
Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase II? and drug responsiveness https://doi.org/10.1124/mol.110.069633 2011
MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin https://doi.org/10.3233/CBM-170970 2018
MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23 https://doi.org/10.26355/eurrev_201805_14953 2018
MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1 https://doi.org/10.26355/eurrev_201804_14821 2018
miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3 https://doi.org/10.2147/OTT.S175745 2018
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 https://doi.org/10.18632/oncotarget.3560 2015
miR-486 suppresses the development of osteosarcoma by regulating PKC-? pathway https://doi.org/10.3892/ijo.2017.3928 2017
MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells https://doi.org/10.3892/etm.2017.4204 2017
miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN https://doi.org/10.18632/aging.102157 2019
Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7 https://doi.org/10.1080/21691401.2019.1620252 2019
Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression https://doi.org/10.1016/j.biopha.2019.108819 2019
LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis https://doi.org/10.1177/1533033819841438 2019
LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1 https://doi.org/10.26355/eurrev_201911_19540 2019
Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma https://doi.org/10.1016/j.prp.2019.152688 2019
MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-?1 expression https://doi.org/10.26355/eurrev_201902_16984 2019
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma https://doi.org/10.1155/2016/1390571 2016
TGF-?1 promotes osteosarcoma cell migration and invasion through the miR-143-versican pathway https://doi.org/10.1159/000369660 2014
MicroRNA-618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN-AKT Pathway Output https://doi.org/10.2147/OTT.S219440 2019
LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis https://doi.org/10.1186/s12935-018-0641-9 2018
Upregulation of circular RNA circ_0001721 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-569 and miR-599 https://doi.org/10.1016/j.biopha.2018.10.072 2019
Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2 https://doi.org/10.26355/eurrev_201903_17229 2019
Circular RNA GLI2 promotes osteosarcoma cell proliferation, migration, and invasion by targeting miR-125b-5p https://doi.org/10.1177/1010428317709991 2017
Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma https://doi.org/10.1038/labinvest.2012.10 2012
MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A https://doi.org/10.1042/BSR20190198 2019
Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1? via miR-143-5p https://doi.org/10.1038/s41419-019-1509-1 2019
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations https://doi.org/10.1073/pnas.0808266105 2008
MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1 https://doi.org/10.1016/j.prp.2019.152554 2019
MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR https://doi.org/10.26355/eurrev_201809_15913 2018
Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells https://doi.org/10.22034/APJCP.2017.18.4.1127 2017
MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression https://doi.org/10.3892/or.2015.4242 2015
The expression and function of miRNA-451 in osteosarcoma https://doi.org/10.1007/s12032-014-0324-x 2015
Expression of miR-29 and STAT3 in osteosarcoma and its effect on proliferation regulation of osteosarcoma cells https://doi.org/10.26355/eurrev_201909_18832 2019
Fibulin-4 is a novel Wnt/?-Catenin pathway activator in human osteosarcoma https://doi.org/10.1016/j.bbrc.2016.05.018 2016
miR-494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma https://doi.org/10.3892/mmr.2017.7709 2017
MiR-204-5p promotes apoptosis and inhibits migration of osteosarcoma via targeting EBF2 https://doi.org/10.1016/j.biochi.2018.12.003 2019
Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1 https://doi.org/10.3892/etm.2017.4426 2017
MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2 https://doi.org/10.1016/j.gene.2019.01.034 2019
Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma https://doi.org/10.3727/096504017X14907375885605 2018
MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met https://doi.org/10.12659/MSM.918454 2019
MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1 https://doi.org/10.14348/molcells.2018.2200 2018
miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1 https://doi.org/10.3892/ol.2017.5709 2017
microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1 https://doi.org/10.3892/mmr.2014.2195 2014
Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma https://doi.org/10.1007/s12253-015-9901-3 2016
Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression https://doi.org/10.3892/etm.2018.6216 2018
Long non-coding RNA XIST serves an oncogenic role in osteosarcoma by sponging miR-137 https://doi.org/10.3892/etm.2018.7032 2019
Long noncoding RNA AFAP1-AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR-4695-5p/TCF4-?-catenin signaling https://doi.org/10.3892/mmr.2018.9131 2018
miR-542-3p overexpression is associated with enhanced osteosarcoma cell proliferation and migration ability by targeting Van Gogh-like 2 https://doi.org/10.3892/mmr.2014.2777 2015
Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression https://doi.org/10.3349/ymj.2018.59.2.226 2018
Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma https://doi.org/10.4149/neo_2014_056 2014
MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors https://doi.org/10.1371/journal.pone.0075815 2013
Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression https://doi.org/10.17179/excli2019-1686 2019
Long Non-Coding RNA TUG1 Modulates Proliferation, Migration, And Invasion Of Acute Myeloid Leukemia Cells Via Regulating miR-370-3p/MAPK1/ERK https://doi.org/10.2147/OTT.S217795 2019
MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2 https://doi.org/10.1186/s11658-019-0184-7 2019
Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2 https://doi.org/10.26355/eurrev_201902_17013 2019
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway https://doi.org/10.1182/blood-2012-07-444729 2013
A novel epigenetic AML1-ETO/THAP10/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis https://doi.org/10.15252/emmm.201607180 2017
MiR-212-5p regulates the proliferation and apoptosis of AML cells through targeting FZD5 https://doi.org/10.26355/eurrev_201812_16540 2018
miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2 https://doi.org/10.1074/jbc.M114.599191 2015
miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN https://doi.org/10.1016/j.cellsig.2018.11.012 2019
MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells https://doi.org/10.1159/000475277 2017
miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis https://doi.org/10.7150/ijbs.29775 2019
MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2 https://doi.org/10.1002/jcb.29192 2020
The miR-17?92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1 https://doi.org/10.1016/j.leukres.2016.04.006 2016
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2. https://doi.org/10.3892/or.2016.4700 2016
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia https://doi.org/10.1038/leu.2012.342 2013
MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R https://doi.org/10.3892/ol.2018.8049 2018
MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia https://doi.org/10.1186/1476-4598-13-79 2014
A critical role of epigenetic inactivation of miR-9 in EVI1(high) pediatric AML https://doi.org/10.1186/s12943-019-0952-z 2019
Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma https://doi.org/10.18632/oncotarget.11861 2016
Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma https://doi.org/10.3892/ol.2016.5362 2016
MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1 https://doi.org/10.2147/OTT.S96561 2016
miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22 https://doi.org/10.12659/msm.900084 2017
Upregulation of miR-214 Induced Radioresistance of Osteosarcoma by Targeting PHLDA2 via PI3K/Akt Signaling https://doi.org/10.3389/fonc.2019.00298 2019
Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1 https://doi.org/10.18632/aging.102280 2019
Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p https://doi.org/10.18632/aging.102563 2019
miRNA signatures associate with pathogenesis and progression of osteosarcoma https://doi.org/10.1158/0008-5472.CAN-11-2663 2012
LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis https://doi.org/10.1002/iub.2001 2019
MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients https://doi.org/10.1007/s13277-014-2811-2 2015
MicroRNA-2682-3p inhibits osteosarcoma cell proliferation by targeting CCND2, MMP8 and Myd88 https://doi.org/0.3892/ol.2018.9029 2018
MicroRNA-2682-3p inhibits osteosarcoma cell proliferation by targeting CCND2, MMP8 and Myd88 https://doi.org/10.3892/ol.2018.9029 2018
Let-7i inhibits the malignant phenotype of osteosarcoma cells by targeting Aurora-B https://doi.org/10.3892/mmr.2015.3798 2015
miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis https://doi.org/10.1016/j.canlet.2018.04.027 2018
MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT https://doi.org/10.1074/jbc.M114.593004 2014
LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/?-catenin pathway through modulating miR-93-3p/FZD7 axis https://doi.org/10.1016/j.bbrc.2019.04.203 2019
miR-202-5p inhibits the migration and invasion of osteosarcoma cells by targeting ROCK1 https://doi.org/10.3892/ol.2018.8694 2018
Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma https://doi.org/10.18632/oncotarget.20678 2017
Long non-coding RNA ZFAS1 sponges miR-486 to promote osteosarcoma cells progression and metastasis in vitro and vivo https://doi.org/10.18632/oncotarget.22032 2017
MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1 https://doi.org/10.1111/jcmm.12966 2017
The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2 https://doi.org/10.1042/BSR20181283 2019
MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma https://doi.org/10.17179/excli2017-932 2018
Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1 https://doi.org/10.3892/ol.2018.8397 2018
MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1 https://doi.org/10.3892/ol.2017.7389 2018
Transcriptional changes induced by the tumor dormancy-associated microRNA-190 https://doi.org/10.4161/trns.25558 2013
miR-185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2 https://doi.org/10.3892/mmr.2019.10534 2019
MiR-214 promotes osteosarcoma tumor growth and metastasis by decreasing the expression of PTEN https://doi.org/10.3892/mmr.2015.4197 2015
MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha https://doi.org/10.1089/dna.2013.1977 2013
Long Noncoding RNA miR210HG Sponges miR-503 to Facilitate Osteosarcoma Cell Invasion and Metastasis https://doi.org/10.1089/dna.2017.3888 2017
MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6 https://doi.org/10.3109/1061186X.2015.1057149 2016
Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma https://doi.org/10.1038/s41419-018-0620-z 2018
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest https://doi.org/10.1158/0008-5472.CAN-08-1569 2008
miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma https://doi.org/10.3892/or.2012.1995 2012
miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1 https://doi.org/10.3892/ol.2018.8927 2018
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R https://doi.org/10.1159/000438653 2016
Potential Regulatory Effects of miR-182-3p in Osteosarcoma via Targeting EBF2 https://doi.org/10.1155/2019/4897905 2019
MiRNA-708/CUL4B axis contributes into cell proliferation and apoptosis of osteosarcoma https://doi.org/10.26355/eurrev_201809_15805 2018
Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/?-Catenin Axis https://doi.org/10.2147/CMAR.S225911 2019
Curcumin Promotes Osteosarcoma Cell Death by Activating miR-125a/ERR? Signal Pathway https://doi.org/10.1002/jcb.25612 2017
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 https://doi.org/10.3892/or_00000994 2010
MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1? protein https://doi.org/10.18632/oncotarget.13672 2017
miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS https://doi.org/10.1042/BSR20170339 2018
Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN https://doi.org/10.3892/ol.2016.5050 2016
MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2 https://doi.org/10.1042/BSR20191237 2019
MicroRNA-384 downregulates SETD8 expression to suppress cell growth and metastasis in osteosarcoma cells https://doi.org/10.26355/eurrev_201803_14566 2018
Autoregulatory loop between TGF-?1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation https://doi.org/10.1038/cddis.2015.225 2015
PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma https://doi.org/10.1038/cddis.2016.159 2016
TGF-?1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma https://doi.org/10.1038/onc.2013.165 2014
Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma https://doi.org/10.1038/onc.2013.188 2014
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma https://doi.org/10.1038/s41388-017-0081-3 2018
miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma https://doi.org/10.1074/jbc.M113.494716 2014
SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma https://doi.org/10.1080/15384101.2015.1005993 2015
MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells https://doi.org/10.1016/j.bbrc.2015.12.067 2016
MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma https://doi.org/10.1002/2211-5463.12177 2017
MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma https://doi.org/10.3892/ol.2015.3503 2015
Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA https://doi.org/10.1089/nat.2017.0673 2017
Let-7b acts as a tumor suppressor in osteosarcoma via targeting IGF1R https://doi.org/10.3892/ol.2018.9793 2019
MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway https://doi.org/10.1111/febs.14416 2018
miR-214-5p Targets ROCK1 and Suppresses Proliferation and Invasion of Human Osteosarcoma Cells https://doi.org/10.3727/096504016X14719078133401 2017
Elevated expression of microRNA-328-3p suppresses aggressive malignant behaviors via targeting matrix metalloprotease 16 in osteosarcoma https://doi.org/10.2147/OTT.S195022 2019
LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway https://doi.org/10.1002/jcb.28426 2019
Downregulation of microRNA-660 inhibits cell proliferation and invasion in osteosarcoma by directly targeting forkhead box O1 https://doi.org/10.3892/mmr.2018.9165 2018
Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis https://doi.org/10.3892/ijo.2017.4127 2017
MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Astrocyte-Elevated Gene-1 (AEG-1) https://doi.org/10.3727/096504017X14886485417426 2017
MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1 https://doi.org/10.1016/j.bbrc.2016.03.040 2016
MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1 https://doi.org/10.1016/j.bbrc.2015.02.101 2015
Biological function of microRNA-30c/SOX9 in pediatric osteosarcoma cell growth and metastasis https://doi.org/10.26355/eurrev_201801_14102 2018
Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma https://doi.org/10.1158/0008-5472.CAN-16-0709 2016
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma https://doi.org/10.1186/s13148-015-0107-z 2015
MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA https://doi.org/10.1371/journal.pone.0125171 2015
MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis https://doi.org/10.18632/oncotarget.1855 2014
MicroRNA-410-3p upregulation suppresses proliferation, invasion and migration, and promotes apoptosis in rhabdomyosarcoma cells https://doi.org/10.3892/ol.2019.10345 2019
Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members https://doi.org/10.1186/1471-2407-14-880 2014
5-Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin-like growth factor 2 expression and reactivating the H19 gene product miR-675, which negatively affects insulin-like growth factors and insulin signaling https://doi.org/10.3892/ijo.2015.2906 2015
In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/?-catenin signaling pathway in osteosarcoma https://doi.org/10.1097/MD.0000000000007245 2017
Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma https://doi.org/10.1139/bcb-2019-0171 2019
MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma https://doi.org/10.26355/eurrev_201812_16621 2018
MicroRNA-203 inhibits proliferation and invasion, and promotes apoptosis of osteosarcoma cells by targeting Runt-related transcription factor 2 https://doi.org/10.1016/j.biopha.2017.05.034 2017
CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells https://doi.org/10.1186/s12943-018-0917-7 2018
MicroRNA-182 downregulates Wnt/?-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9 https://doi.org/10.18632/oncotarget.21167 2017
MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5 https://doi.org/10.1002/jcp.28030 2019
miR-34c-3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS https://doi.org/10.3892/mmr.2017.6108 2017
miR-23b-3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1 https://doi.org/10.3892/mmr.2018.9611 2018
MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1 https://doi.org/10.3892/etm.2016.3880 2016
MALAT1 Promotes the Proliferation and Metastasis of Osteosarcoma Cells By Activating the Rac1/JNK Pathway Via Targeting MiR-509 https://doi.org/10.3727/096504017X14957939026111 2018
Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma https://doi.org/10.1038/cgt.2017.1 2017
Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors https://doi.org/10.1158/1541-7786.MCR-18-1071 2019
miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1 https://doi.org/10.33594/000000039 2019
Hsa_circ_0051079 functions as an oncogene by regulating miR-26a-5p/TGF-?1 in osteosarcoma https://doi.org/10.1186/s13578-019-0355-2 2019
Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R https://doi.org/10.1002/jcp.28787 2019
MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN https://doi.org/10.1177/1010428317705341 2017
VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma https://doi.org/10.1007/s11010-014-2265-2 2015
MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma https://doi.org/10.1371/journal.pone.0053906 2013
miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3 https://doi.org/10.2147/OTT.S193937 2019
MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis https://doi.org/10.1371/journal.pone.0083571 2013
Long non-coding RNA CCAT1/miR-148a axis promotes osteosarcoma proliferation and migration through regulating PIK3IP1 https://doi.org/10.1093/abbs/gmx041 2017
The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression https://doi.org/10.3892/ijmm.2014.1963 2014
MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway https://doi.org/10.3892/ijmm.2019.4333 2019
MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/?-catenin signaling pathway in a DKK1-dependent manner https://doi.org/10.3892/or.2018.6456 2018
RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1) https://doi.org/10.12659/MSM.917375 2019
miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1 https://doi.org/10.1002/jcb.27832 2019
Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression https://doi.org/10.3892/or.2017.6065 2018
Post-Transcriptional Control of Angiotensin II Type 1 Receptor Regulates Osteosarcoma Cell Death https://doi.org/10.1159/000487719 2018
Silencing lncRNA ZFAS1 or elevated microRNA-135a represses proliferation, migration, invasion and resistance to apoptosis of osteosarcoma cells https://doi.org/10.1186/s12935-019-1049-x 2019
Long non-coding RNA TUG1 regulates the progression and metastasis of osteosarcoma cells via miR-140-5p/PFN2 axis https://doi.org/10.26355/eurrev_201911_19541 2019
TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis https://doi.org/10.1016/j.prp.2018.12.031 2019
LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma https://doi.org/10.1016/j.biopha.2019.108695 2019
LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p https://doi.org/10.26355/eurrev_201901_16753 2019
MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression https://doi.org/10.4238/2015.December.14.14 2015
MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma https://doi.org/10.1159/000488612 2018
miR-155 regulates HGAL expression and increases lymphoma cell motility https://doi.org/10.1182/blood-2011-08-370536 2012
Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R https://doi.org/10.1002/jcp.28787 2019
Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. https://doi.org/10.1038/leu.2010.282 2011
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer https://doi.org/10.1073/pnas.1009009107 2010
MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma https://doi.org/10.3892/ol.2018.8238 2018
Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/?-catenin pathway by regulating miR-1205/APC2 axis https://doi.org/10.1016/j.bbrc.2018.05.184 2018
MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis https://doi.org/10.1002/jcp.28843 2019
CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value https://doi.org/10.2147/CMAR.S178213 2018
miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway https://doi.org/10.3892/or.2017.5484 2017
Overexpression of miR-140 Inhibits Proliferation of Osteosarcoma Cells via Suppression of Histone Deacetylase 4 https://doi.org/10.3727/096504016X14732510786564 2017
miR-186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis https://doi.org/10.3892/or.2018.6394 2018
MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK-STAT3 pathway https://doi.org/10.1002/jcb.27568 2018
MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4 https://doi.org/10.1080/07357907.2017.1415348 2018
MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma https://doi.org/10.1111/jcmm.14217 2019
Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1 https://doi.org/10.1016/j.ijbiomac.2019.04.016 2019
MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2 https://doi.org/10.1038/s41598-017-13353-9 2017
miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9) https://doi.org/10.1007/s10529-017-2445-8 2018
miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma https://doi.org/10.1089/dna.2019.4870 2019
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer https://doi.org/10.18632/oncotarget.10020 2016
MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 via Targeting Caspase 8 https://doi.org/10.3727/096504017X14841698396829 2017
SphK2 over-expression promotes osteosarcoma cell growth https://doi.org/10.18632/oncotarget.22314 2017
miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3 https://doi.org/10.3892/or.2015.4393 2016
MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1 https://doi.org/10.1159-000358700 2014
microRNA-452 exerts growth-suppressive activity against T-cell acute lymphoblastic leukemia. https://doi.org/10.1136/jim-2017-000591 2017
Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. https://doi.org/10.1080/10428190802626632 2009
Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma https://doi.org/10.1038/cddis.2016.143 2016
Down-regulation of miR-3928 promoted osteosarcoma growth https://doi.org/10.1159-000358718 2014
miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway https://doi.org/10.3892/ol.2016.5355 2016
Tumor-suppressing effects of miR451 in human osteosarcoma https://doi.org/10.1007/s12013-013-9783-5 2014
MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma https://doi.org/10.3892/ol.2017.6393 2017
MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation https://doi.org/10.1016/j.biopha.2013.03.013 2013
MicroRNA-106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma https://doi.org/10.3892/ol.2019.10666 2019
Nuclear paraspeckle assembly transcript 1 promotes the metastasis and epithelial-mesenchymal transition of hepatoblastoma cells by inhibiting miR-129-5p https://doi.org/10.3892/ol.2017.6995 2017
Rs217727 polymorphism in H19 promotes cell apoptosis by regulating the expressions of H19 and the activation of its downstream signaling pathway https://doi.org/10.1002/jcp.27485 2019
H19 suppresses the growth of hepatoblastoma cells by promoting their apoptosis via the signaling pathways of miR-675/FADD and miR-138/PTK2 https://doi.org/10.1002/jcb.27797 2019
MiR-34c inhibits osteosarcoma metastasis and chemoresistance https://doi.org/10.1007/s12032-014-0972-x 2014
H19 suppresses the growth of hepatoblastoma cells by promoting their apoptosis via the signaling pathways of miR-675/FADD and miR-138/PTK2 https://doi.org/doi.org/10.1002/jcb.27797 2019
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma https://doi.org/10.18632/oncotarget.2418 2014
miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1 https://doi.org/10.1038/mt.2014.197 2015
MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells https://doi.org/10.1371/journal.pone.0115300 2014
MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression https://doi.org/10.1007/s11356-018-1331-9 2018
miR-376a inhibits the proliferation and invasion of osteosarcoma by targeting FBXO11 https://doi.org/10.1007/s13577-019-00256-2 2019
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma https://doi.org/10.1177/2058738418786656 2018
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma https://doi.org/10.1111/cpr.12515 2018
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting ?-catenin and Wnt signaling https://doi.org/10.1002/hep4.1029 2017
MiR-492 regulates metastatic properties of hepatoblastoma via CD44 https://doi.org/10.1111/liv.13687 2018
A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. https://doi.org/10.1093/hmg/ddr428 2011
Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells. https://doi.org/10.1038/leu.2013.308 2013
Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells https://doi.org/10.1159/000430383 2015
STAT3-Activated Long Non-Coding RNA Lung Cancer Associated Transcript 1 Drives Cell Proliferation, Migration, and Invasion in Hepatoblastoma Through Regulation of the miR-301b/STAT3 Axis https://doi.org/10.1089/hum.2018.146 2019
Dysregulation of liver developmental microRNA contribute to hepatic carcinogenesis https://doi.org/10.1016/j.jfma.2019.09.018 2019
MicroRNA-26-5p functions as a new inhibitor of hepatoblastoma by repressing lin-28 homolog B and aurora kinase a expression https://doi.org/10.1002/hep4.1185 2018
MiR-100 regulates cell viability and apoptosis by targeting ATM in pediatric acute myeloid leukemia https://doi.org/10.1016/j.bbrc.2019.11.156 2019
MicroRNA-339-5p inhibits cell proliferation of acute myeloid leukaemia by directly targeting SOX4 https://doi.org/10.3892/mmr.2018.9552 2018
Deregulated MIR335 that targetsMAPK1is implicated in poor outcome of paediatric acute lymphoblastic leukaemia https://doi.org/10.1111/bjh.12489 2013
Differential Co-expression and Regulatory Network Analysis Uncover the Relapse Factor and Mechanism of T Cell Acute Leukemia. https://doi.org/10.1016/j.omtn.2018.05.003 2018
MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. https://doi.org/10.1038/bjc.2013.562 2013
Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia. Correlation between TLX3 and miR125b expression in T-ALL, both factors being implicated in the control of leukemic cell growth. https://doi.org/10.1155/2018/5724686 2018
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations https://doi.org/10.1182/blood-2010-03-277012 2011
miR-155 regulative network in FLT3 mutated acute myeloid leukemia https://doi.org/10.1016/j.leukres.2015.04.017 2015
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias https://doi.org/10.1038/bcj.2011.24 2011
CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis https://doi.org/10.1016/j.exphem.2018.10.011 2019
Long noncoding RNA MIAT promotes the progression of acute myeloid leukemia by negatively regulating miR-495 https://doi.org/10.1016/j.leukres.2019.106265 2019
Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia https://doi.org/10.1016/j.cellsig.2014.12.003 2015
Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cells growth, migration and invasion https://doi.org/10.1016/j.yexmp.2019.04.011 2019
The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML) https://doi.org/10.1186/1471-2350-14-74 2013
Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1 https://doi.org/10.1016/j.biopha.2018.02.026 2018
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia. https://doi.org/10.1182/bloodadvances.2017005538 2017
MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2 https://doi.org/10.1080/00498254.2017.1390624 2018
MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2. https://doi.org/10.1002/jgm.2898 2016
microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling. https://doi.org/10.3349/ymj.2019.60.10.924 2019
MicroRNA-185-5p restores glucocorticoid sensitivity by suppressing the mammalian target of rapamycin complex (mTORC) signaling pathway to enhance glucocorticoid receptor autoregulation. https://doi.org/10.1080/10428194.2017.1296143 2017
MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4. https://doi.org/1936-2625 (Electronic) 2015
MicroRNA-9 suppresses cancer proliferation and cell cycle progression in acute lymphoblastic leukemia with inverse association of neuropilin-1. https://doi.org/10.1002/jcb.26799 2017
miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia. https://doi.org/10.3892/or.2017.5425 2017
The downregulation of miR-3173 in B-cell acute lymphoblastic leukaemia promotes cell invasion via PTK2. https://doi.org/10.1016/j.bbrc.2017.10.013 2017
MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis https://doi.org/10.5483/bmbrep.2018.51.9.036 2018
Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. https://doi.org/10.1038/leu.2012.242 2013
A Double Negative Loop Comprising ETV6/ RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia https://doi.org/10.1371/journal.pone.0142863 2015
MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3 https://doi.org/10.26355/eurrev_201905_17780 2019
Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma https://doi.org/10.1042/BSR20160062 2016
MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia https://doi.org/10.1182/blood-2011-10-385716 2012
Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia https://doi.org/10.1016/j.febslet.2015.04.061 2015
SHIP1 is targeted by miR-155 in acute myeloid leukemia https://doi.org/10.3892/or.2014.3435 2014
An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells https://doi.org/10.18632/oncotarget.18127 2017
MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target https://doi.org/10.1016/j.biopha.2017.11.002 2018
Long Noncoding RNA LINC00152 Facilitates the Leukemogenesis of Acute Myeloid Leukemia by Promoting CDK9 Through miR-193a https://doi.org/10.1089/dna.2018.4482 2019
Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia https://doi.org/10.1007/s13277-015-3734-2 2016
Targeting miR-193a-AML1-ETO-?-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation. https://doi.org/10.1111/jcmm.14399 2019
Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia https://doi.org/10.1002/jcp.27393 2019
LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells https://doi.org/10.26355/eurrev_201904_17569 2019
CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis https://doi.org/10.7150/thno.29515 2019
MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway https://doi.org/10.1111/j.1478-3231.2011.02750.x 2012
Crosstalk between microRNA-122 and FOX family genes in HepG2 cells https://doi.org/10.1177/1535370216681548 2016
MicroRNA-122 mimic transfection contributes to apoptosis in HepG2 cells https://doi.org/10.3892/mmr.2015.4254 2015
miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor https://doi.org/10.1186/s12885-019-5609-1 2019
The anti-cancer effects of cisplatin on hepatic cancer are associated with modulation of miRNA-21 and miRNA-122 expression. https://doi.org/ - 2016
Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma https://doi.org/10.1007/s12291-017-0651-8 2018
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. https://doi.org/10.1093/carcin/bgs126. 2012
MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma https://doi.org/10.1007/s13277-015-3644-3 2015
miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cells https://doi.org/10.2478/v10019-012-0025-z 2011
MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation https://doi.org/10.1016/j.bbrc.2016.12.091 2017
MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1. https://doi.org/- 2016
MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1 https://doi.org/10.2147/OTT.S87976 2015
miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1 https://doi.org/10.2147/OTT.S96902 2016
MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway https://doi.org/10.3390/ijms14048556 2013
MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1 https://doi.org/10.18632/oncotarget.3916 2015
MicroRNA-499a-5p inhibits osteosarcoma cell proliferation and differentiation by targeting protein phosphatase 1D through protein kinase B/glycogen synthase kinase 3? signaling https://doi.org/10.3892/ol.2018.7814 2018
MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway https://doi.org/10.1124/mol.118.114207 2019
miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1 https://doi.org/10.3892/ol.2018.8359 2018
MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p https://doi.org/10.1080/15384101.2017.1288324 2017
LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141 https://doi.org/10.1186/s12929-017-0353-9 2017
MALAT1 promotes proliferation, migration, and invasion of MG63 cells by upregulation of TGIF2 via negatively regulating miR-129 https://doi.org/10.2147/OTT.S182993 2018
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3 https://doi.org/10.1016/j.bbrc.2011.10.117 2011
von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro https://doi.org/10.1042/BSR20180372 2018
MicroRNA-20b Downregulates HIF-1? and Inhibits the Proliferation and Invasion of Osteosarcoma Cells https://doi.org/10.3727/096504016X14562725373752 2016
Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells https://doi.org/10.3892/or.2016.5182 2016
miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN https://doi.org/10.3892/ol.2018.9646 2019
GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3 https://doi.org/10.18632/oncotarget.12839 2016
MicroRNA-199a-5p inhibits VEGF-induced tumorigenesis through targeting oxidored-nitro domain-containing protein 1 in human HepG2 cells https://doi.org/10.3892/or.2016.4550 2016
miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1 https://doi.org/10.1186/s12943-015-0349-6 2015
MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells https://doi.org/10.3892/mmr.2014.2526 2014
MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/?-catenin pathway https://doi.org/10.1038/srep08087 2015
MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells https://doi.org/10.3727/096504016X14719078133366 2017
MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1 https://doi.org/10.1155/2018/9870693 2018
Expression and function of microRNA-497 in human osteosarcoma https://doi.org/10.3892/mmr.2016.5256 2016
MiR-19a Promotes Migration And Invasion By Targeting RHOB In Osteosarcoma https://doi.org/10.2147/OTT.S218047 2019
MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma https://doi.org/10.1159/000438556 2015
MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma https://doi.org/10.1016/j.febslet.2015.08.034 2015
miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R https://doi.org/10.1016/j.bbrc.2016.11.145 2017
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells https://doi.org/10.1111/jcmm.13594 2018
Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG) https://doi.org/10.12659/msm.899114 2016
LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a https://doi.org/10.1016/j.biocel.2019.105666 2019
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3? in hepatocellular carcinoma cells https://doi.org/10.1186/1471-2407-14-879 2014
microRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma https://doi.org/10.3892/or.2015.3734 2015
miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2 https://doi.org/10.1007/s13577-014-0105-z 2015
MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma https://doi.org/10.1016/j.biopha.2017.07.029 2017
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway https://doi.org/10.1007/s13277-015-4456-1 2015
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma https://doi.org/10.1016/j.bbrc.2011.06.191 2011
miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma. https://doi.org/10.7314/apjcp.2013.14.2.885 2013
MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma https://doi.org/10.1002/jcb.26526 2017
miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC https://doi.org/10.1038/srep23091 2016
MiR-27a Promotes Hepatocellular Carcinoma Cell Proliferation Through Suppression of its Target Gene Peroxisome Proliferator-activated Receptor ? https://doi.org/10.4103/0366-6999.154302 2015
miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas https://doi.org/10.1186/s12885-018-5205-9 2018
Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis 10.1371/journal.pone.0117994https://doi.org/ 2015
Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis https://doi.org/10.1371/journal.pone.0117994 2015
The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR https://doi.org/10.1016/j.ajpath.2015.01.025 2015
Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro https://doi.org/10.1111/cas.12156 2013
Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression https://doi.org/10.1016/j.gene.2019.03.052 2019
Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma https://doi.org/10.1186/1756-9966-32-21 2013
MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF https://doi.org/10.1007/s13277-015-4427-6 2015
MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma https://doi.org/10.1371/journal.pone.0124266 2015
Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma https://doi.org/10.1038/cgt.2015.51 2015
Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB https://doi.org/10.1158/1541-7786.MCR-09-0465 2010
LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21 https://doi.org/10.1089/cbr.2018.2684 2019
miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b https://doi.org/10.1080/15384101.2019.1676087 2019
MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor https://doi.org/10.1016/j.biopha.2016.12.121 2017
MicroRNA expression and functional profiles of osteosarcoma https://doi.org/10.1159/000357408 2014
MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1 https://doi.org/10.1007/s13277-015-3213-9 2015
HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12 https://doi.org/10.3892/or.2016.5026 2016
MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3 https://doi.org/10.1186/1471-2407-13-469 2013
MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis https://doi.org/10.26355/eurrev_201902_17120 2019
MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression https://doi.org/10.1182/blood-2010-09-301994 2011
Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis https://doi.org/10.1038/s41388-017-0055-5 2018
miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma https://doi.org/10.3892/or.2012.1682 2012
Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101 https://doi.org/10.1007/s00277-014-2021-4 2014
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma https://doi.org/10.18632/oncotarget.3729 2015
Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development https://doi.org/10.1093/carcin/bgs404 2013
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth https://doi.org/10.1172/JCI78488 2015
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes https://doi.org/10.1182/blood-2008-07-163907 2009
Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma? https://doi.org/10.1002/cncr.26566 2011
Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation https://doi.org/10.1007/s00432-011-1076-z 2011
miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1 https://doi.org/10.1186/s12935-016-0328-z 2016
MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells https://doi.org/10.1007/s13277-012-0396-1 2012
miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer https://doi.org/10.3892/ol.2016.5326 2016
miR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2 https://doi.org/10.3892/ijmm.2015.2341 2015
miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3 https://doi.org/10.3892/or.2017.5702 2017
MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells https://doi.org/10.3892/or.2012.1850 2012
MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1 https://doi.org/10.1016/j.lfs.2012.08.015 2012
MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPAR? in human hepatocellular carcinoma https://doi.org/10.3892/etm.2017.4236 2017
microRNA-1301-mediated inhibition of tumorigenesis https://doi.org/10.3892/or.2011.1589 2011
MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A https://doi.org/10.1016/j.prp.2018.04.012 2018
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma https://doi.org/10.2147/OTT.S122992 2016
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma https://doi.org/10.3892/or.2017.5423 2017
miR-211 suppresses hepatocellular carcinoma by downregulating SATB2 https://doi.org/10.18632/oncotarget.3265 2015
MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells https://doi.org/10.3892/ijmm.2014.1800 2014
MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma https://doi.org/10.1007/s13277-015-4462-3 2015
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4 https://doi.org/10.7150/jca.25569 2018
miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2 https://doi.org/10.3727/096504018X15148192843443 2018
miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin https://doi.org/10.14348/molcells.2016.2161 2016
MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells https://doi.org/10.3892/ol.2015.3832 2015
miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting https://doi.org/10.22038/IJBMS.2017.9010 2017
MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression https://doi.org/10.3892/ijmm.2016.2754 2016
MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma https://doi.org/10.18632/oncotarget.9886 2016
miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway https://doi.org/10.3892/or.2017.5683 2017
MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4) https://doi.org/10.1007/s11010-014-2234-9 2014
MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein* https://doi.org/10.1074/jbc.M113.502682 2013
miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition https://doi.org/10.1038/s41598-018-20258-8 2018
MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like. https://doi.org/10.1159/000488734 2018
MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis https://doi.org/10.1186/s12935-017-0471-1 2017
Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. https://doi.org/10.1016/j.bbrc.2013.08.032 2013
MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X https://doi.org/10.1186/1471-2407-14-393 2014
MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA https://doi.org/10.1016/j.bbrc.2015.11.008 2015
MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR https://doi.org/10.1038/aps.2014.59 2014
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2 https://doi.org/10.1186/s13045-015-0229-y 2016
miR-26a Promoted by Interferon-Alpha Inhibits Hepatocellular Carcinoma Proliferation and Migration by Blocking EZH2 https://doi.org/10.1089/gtmb.2014.0245 2015
MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2?/Akt/HIF-1? Pathway in Hepatocellular Carcinoma https://doi.org/10.1371/journal.pone.0077957 2013
MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells https://doi.org/10.3892/mmr.2015.4051 2015
MicroRNA-130b Promotes Cell Aggressiveness by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Human Hepatocellular https://doi.org/10.3390/ijms151120486 2014
microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro. https://doi.org/10.24920/j1001-9242.2007.005 2017
Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways https://doi.org/10.1242/jcs.122895 2013
MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2 https://doi.org/10.3892/mmr.2017.7828 2017
MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells https://doi.org/10.1007/s13277-016-5230-8 2016
MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells https://doi.org/10.3727/096504017X14850151453092 2017
MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1 https://doi.org/10.1016/j.yexcr.2016.03.027 2016
miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor https://doi.org/10.3892/or.2015.4321 2015
MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma https://doi.org/10.3892/mmr.2015.3232 2015
MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma https://doi.org/10.1007/s13277-015-3749-8 2015
miR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3 https://doi.org/10.3892/ijo.2015.3112 2015
MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling https://doi.org/10.1007/s11010-017-3176-9 2017
miR-203 inhibits proliferation of HCC cells by targeting survivin https://doi.org/10.1002/cbf.2863 2012
MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a https://doi.org/10.3892/mmr.2016.4995 2016
MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma https://doi.org/10.3892/or.2016.5290 2016
MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA https://doi.org/10.1016/j.bbrc.2012.08.075 2012
miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA https://doi.org/10.1038/aps.2017.62 2017
MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma https://doi.org/10.1111/j.1742-4658.2011.08120.x 2011
miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC) https://doi.org/10.1016/j.biopha.2013.09.005 2013
Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells https://doi.org/10.3892/or.2012.2138 2012
Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression https://doi.org/10.1038/srep34034 2016
MiR-34a is Involved in the Decrease of ATP Contents Induced by Resistin Through Target on ATP5S in HepG2 Cells https://doi.org/10.1007/s10528-015-9693-x 2015
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells https://doi.org/10.1016/j.canlet.2008.09.035 2009
MicroRNA-4262 activates the NF-?B and enhances the proliferation of hepatocellular carcinoma cells https://doi.org/10.1016/j.ijbiomac.2016.01.019 2016
MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma https://doi.org/10.1159/000489594 2018
MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737 https://doi.org/10.3748/wjg.v22.i23.5364 2016
MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition https://doi.org/10.1111/liv.12190 2013
miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma https://doi.org/10.18632/oncotarget.4407 2015
Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma https://doi.org/10.1177/1533034617735931 2017
MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B https://doi.org/10.1007/s11010-013-1940-z 2014
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma https://doi.org/10.3892/ijo.2017.3852 2017
miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E https://doi.org/10.3892/or.2016.5220 2016
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor https://doi.org/10.2147/OTT.S106351 2016
MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1? https://doi.org/10.1371/journal.pone.0115565 2014
miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling https://doi.org/10.3892/ol.2012.742 2012
MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion https://doi.org/10.1111/j.1440-1746.2009.05971.x 2009
MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues https://doi.org/10.3892/mmr.2015.4012 2015
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression https://doi.org/10.1002/ijc.24655 2010
MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6 https://doi.org/10.3892/etm.2017.4348 2017
MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors https://doi.org/10.1002/hep.27816 2015
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas https://doi.org/10.1038/leu.2010.230 2011
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma https://doi.org/10.1182/blood-2011-05-354654 2011
MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells https://doi.org/10.1007/s00432-017-2575-3 2018
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation https://doi.org/10.1002/path.4539 2015
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing https://doi.org/10.1371/journal.pone.0042193 2012
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma https://doi.org/10.1038/sj.emboj.7601794 2007
MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16 https://doi.org/10.1158/1078-0432.CCR-14-2947 2015
MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression https://doi.org/10.1016/j.ajpath.2012.01.008 2012
Low expression of miR-150 in pediatric intestinal Burkitt lymphoma https://doi.org/10.1016/j.yexmp.2014.02.015 2014
MicroRNA-520a attenuates proliferation of Raji cells through inhibition of AKT1/NF-?B and PERK/eIF2? signaling pathway https://doi.org/10.3892/or.2016.4975 2016
The role of microRNA-150 as a tumor suppressor in malignant lymphoma https://doi.org/10.1038/leu.2011.81 2011
Epigenetic inactivation of the miR-124-1 in haematological malignancies https://doi.org/10.1371/journal.pone.0019027 2011
MicroRNA-204 targets signal transducer and activator of transcription 5 expression and inhibits proliferation of B-cell lymphoma cells https://doi.org/10.3892/mmr.2015.3298 2015
Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-?B/miR-155/PU.1 pathway https://doi.org/10.1186/s12885-017-3145-4 2017
Patterns of microRNA expression characterize stages of human B-cell differentiation https://doi.org/10.1182/blood-2008-09-178186 2009
EBV-BART-6-3p and cellular microRNA-197 compromise the immune defense of host cells in EBV-positive Burkitt lymphoma https://doi.org/10.3892/mmr.2017.6173 2017
Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma https://doi.org/10.12659/msm.897306 2016
NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism https://doi.org/10.1002/path.4171 2013
miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner https://doi.org/10.1002/jcb.27189 2018
Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line https://doi.org/10.1016/j.bbrc.2017.06.050 2017
MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil https://doi.org/10.1159/000374036 2015
Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma https://doi.org/10.1158/0008-5472.CAN-06-4607 2007
The potential combinational effect of miR-34a with celecoxib in osteosarcoma https://doi.org/10.1097/CAD.0000000000000530 2017
Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a https://doi.org/10.1590/1414-431X20187665 2018
Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223 https://doi.org/10.1016/j.biopha.2018.07.109 2018
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells https://doi.org/10.1002/jcp.25291 2016
MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27 https://doi.org/10.3892/ijo.2018.4374 2018
miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells https://doi.org/10.3892/or.2015.3797 2015
MicroRNA485-3p negatively regulates the transcriptional co-repressor CtBP1 to control the oncogenic process in osteosarcoma cells https://doi.org/10.7150/ijbs.26335 2018
Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion https://doi.org/10.1007/s13577-019-00298-6 2019
Regulatory effects of microRNA-184 on osteosarcoma via the Wnt/?-catenin signaling pathway https://doi.org/10.3892/mmr.2018.9184 2018
Overexpression of miR-100 inhibits growth of osteosarcoma through FGFR3 https://doi.org/10.1007/s13277-015-3581-1 2015
MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A https://doi.org/10.26355/eurrev_201811_16254 2018
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway https://doi.org/10.1182/blood-2010-10-315432 2011
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma https://doi.org/10.1073/pnas.1009719107 2010
Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis https://doi.org/10.1016/j.yexmp.2015.03.006 2015
MicroRNA profiling in human medulloblastoma. https://doi.org/10.1002/ijc.23948 2008
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. https://doi.org/10.1007/s11060-008-9624-3 2008
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. https://doi.org/10.1093/neuonc/noq179 2011
Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma. https://doi.org/10.3389/fonc.2013.00254 2013
Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4 https://doi.org/10.1016/j.biopha.2015.08.012 2015
MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16 https://doi.org/10.1159/000438575 2015
MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4 https://doi.org/10.1177/1010428317703841 2017
MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway https://doi.org/10.26355/eurrev_201905_17783 2019
miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo https://doi.org/10.1002/1873-3468.13387 2019
MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA https://doi.org/MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA 2018
miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma https://doi.org/10.1016/j.bbrc.2018.07.060 2018
CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of ?-catenin/LEF1 complex via effects on chromatin remodeling https://doi.org/10.1186/s12943-019-1076-1 2019
LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma https://doi.org/10.1177/2058738418820743 2019
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN https://doi.org/10.3892/or.2016.4719 2016
miR-548d-3p inhibits osteosarcoma by downregulating KRAS https://doi.org/10.18632/aging.102097 2019
miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2 https://doi.org/10.1007/s13277-015-3568-y 2015
Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients https://doi.org/10.1016/j.prp.2019.152686 2019
miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma https://doi.org/10.1016/j.febslet.2013.03.007 2013
microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression https://doi.org/10.3892/ol.2018.8218 2018
Potential Role of Long Non-Coding RNA ANRIL in Pediatric Medulloblastoma Through Promotion on Proliferation and Migration by Targeting miR-323. https://doi.org/10.1002/jcb.26141 2017
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. https://doi.org/10.4103/0973-1482.77072 2010
MicroRNA-21 suppression impedes medulloblastoma cell migration. https://doi.org/10.1016/j.ejca.2011.06.041 2011
MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). https://doi.org/10.1111/bpa.12014 2012
"MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma" https://doi.org/10.1159/000430308 2015
miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. https://doi.org/10.1016/j.humpath.2009.02.003 2009
miR-522-3p Promotes Osteosarcoma Cell Growth By Regulating Glucose Uptake And GLUT1 Expression https://doi.org/10.2147/OTT.S217324 2019
miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2 https://doi.org/10.3892/ol.2018.9451 2018
Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation https://doi.org/10.1016/j.cellsig.2009.07.019 2009
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells https://doi.org/10.1038/sj.onc.1210293 2007
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells https://doi.org/10.1073/pnas.0700071104 2007
miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4? https://doi.org/10.1080/21691401.2019.1637886 2019
BMP-2 and miR-29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells https://doi.org/10.3892/ol.2019.10229 2019
MicroRNA-125b is a novel negative regulator of p53 https://doi.org/10.1101/gad.1767609 2009
Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis https://doi.org/10.1080/21691401.2019.1648285 2019
Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/?-catenin signaling pathway by enhancing AXIN1 https://doi.org/10.1016/j.yexmp.2019.03.001 2019
MicroRNA-106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2 https://doi.org/10.3892/or.2018.6601 2018
High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. https://doi.org/10.1038/s41419-019-1926-1 2019
Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. https://doi.org/10.1038/bjc.2013.764 2013
Expression of miR-124 inhibits growth of medulloblastoma cells. https://doi.org/10.1093/neuonc/nos281 2013
MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets https://doi.org/10.1128/MCB.01694-08 2009
microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma. https://doi.org/10.1371/journal.pone.0137845 2015
Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211. https://doi.org/10.1159/000493712 2018
A statin-regulated microRNA represses human c-Myc expression and function. https://doi.org/10.1002/emmm.201101045 2012
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. https://doi.org/10.1038/emboj.2008.172 2008
Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway https://doi.org/10.1002/jcb.27559 2018
MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1. https://doi.org/10.3892/etm.2017.5016 2017
miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164. https://doi.org/10.3892/ijmm.2014.1749 2014
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. https://doi.org/10.1093/neuonc/nos002 2012
Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells. https://doi.org/10.1080/09168451.2018.1553604 2018
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene https://doi.org/10.1158/1541-7786.MCR-07-2102 2008
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM https://doi.org/10.1371/journal.pone.0002236 2008
microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7 https://doi.org/10.26355/eurrev_201901_16885 2019
MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 https://doi.org/10.1038/cdd.2010.172 2011
MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2. https://doi.org/10.18632/oncotarget.2043 2014
miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN. https://doi.org/10.1111/nan.12169 2015
MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1. https://doi.org/10.18632/oncoscience.137 2015
miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma. https://doi.org/10.3892/mmr.2013.1639 2013
Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells. https://doi.org/10.1038/onc.2013.151 2013
MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1. https://doi.org/10.1111/bpa.12136 2014
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. https://doi.org/10.1371/journal.pone.0108514 2014
miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells. https://doi.org/10.1016/j.cellsig.2014.06.014 2014
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. https://doi.org/10.1007/s00401-012-0969-5 2012
MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation https://doi.org/10.1158/0008-5472.CAN-10-1534 2010
Regulation of Nuclear Receptor Nur77 by miR-124. https://doi.org/10.1371/journal.pone.0148433 2016
miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells https://doi.org/10.1002/mc.20647 2010
miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro https://doi.org/10.1016/j.bbrc.2010.03.076 2010
miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro https://doi.org10.1016/j.bbrc.2010.03.076 2010
MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma https://doi.org/10.1016/j.canlet.2011.01.016 2011
Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells https://doi.org/10.1186/1471-2199-11-95 2010
A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation https://doi.org/10.1093/nar/gkq604 2010
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma https://doi.org/10.1093/carcin/bgr073 2011
LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway https://doi.org/10.1159/000495550 2018
MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1 https://doi.org/10.18632/oncotarget.6199 2015
miR-142-5p suppresses proliferation and promotes apoptosis of human osteosarcoma cell line, HOS, by targeting PLA2G16 through the ERK1/2 signaling pathway https://doi.org/10.3892/ol.2018.9712 2019
Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p https://doi.org/10.26355/eurrev_201909_18828 2019
Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP https://doi.org/10.1016/j.cellsig.2019.109460 2020
MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2 https://doi.org/10.26355/eurrev_201911_19419 2019
MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM https://doi.org/10.1371/journal.pone.0114585 2014
Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma https://doi.org/10.3892/ol.2019.10203 2019
MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival https://doi.org/10.1038/cdd.2010.164 2011
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma https://doi.org/10.1038/bjc.2011.220 2011
Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a https://doi.org/10.1021/pr1006697 2011
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma https://doi.org/10.1073/pnas.0913517107 2010
MicroRNA-222 contributed to cell proliferation, invasion and migration via regulating YWHAG in osteosarcoma https://doi.org/10.26355/eurrev_201805_14952 2018
Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211 https://doi.org/10.1042/BSR20190291 2019
LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis https://doi.org/10.1002/jcb.29451 2019
Long non-coding RNA HOXA11-AS functions as a competing endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p in osteosarcoma https://doi.org/10.1016/j.biopha.2017.05.081 2017
MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2 https://doi.org/10.1007/s13277-015-3396-0 2015
Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression https://doi.org/10.1080/15384101.2019.1656478 2019
miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease https://doi.org/10.18632/oncotarget.11003 2016
Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcoma https://doi.org/10.3892/etm.2017.4870 2017
Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma https://doi.org/10.1016/j.bbrc.2017.11.028 2018
miR-367 promotes proliferation and stem-like traits in medulloblastoma cells. https://doi.org/10.1111/cas.12733 2015
lncRNA SNHG1 negatively regulates miRNA-101-3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma https://doi.org/10.3892/ijmm.2018.4039 2019
MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1 https://doi.org/10.17179/excli2017-258 2017
Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma https://doi.org/10.1089/cbr.2018.2503 2018
Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells https://doi.org/10.3892/ol.2015.3036 2015
miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3 https://doi.org/10.1007/s13277-015-4527-3 2016
MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. https://doi.org/10.1038/s41467-018-06808-8 2018
A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2 https://doi.org/10.1371/journal.pone.0040269 2012
Regulation of UHRF1 by microRNA-378 modulates medulloblastoma cell proliferation and apoptosis. https://doi.org/10.3892/or.2017.5939 2017
Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition. https://doi.org/10.1016/j.bbrc.2017.07.140 2017
Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21. https://doi.org/10.1002/mc.22778 2018
Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment. https://doi.org/10.1016/j.ajpath.2015.10.020 2016
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. https://doi.org/10.4161/rna.8.5.16041 2011
Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells https://doi.org/10.1007/s11064-012-0936-5 2013
Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells https://doi.org/10.1016/j.brainres.2012.03.017 2012
GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma https://doi.org/10.3892/or.2016.4949 2016
miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma https://doi.org/10.1016/j.jbo.2016.05.001 2016
miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy https://doi.org/10.2147/OTT.S219977 2019
MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7 https://doi.org/10.1016/j.abb.2017.07.011 2017
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7 https://doi.org/10.1007/s10238-015-0398-6 2017
Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death https://doi.org/10.1038/onc.2016.68 2016
Expression and regulatory effects of microRNA-182 in osteosarcoma cells: A pilot study https://doi.org/10.3892/ol.2016.4375 2016
miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1 https://doi.org/10.3892/or.2017.5983 2017
miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a https://doi.org/10.1016/j.febslet.2013.09.044 2013
MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma https://doi.org/10.1186/s12935-017-0499-2 2018
MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1 https://doi.org/10.3892/ol.2014.1794 2014
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2 https://doi.org/10.1186/1476-4598-9-83 2010
MiR-27b targets PPAR? to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells https://doi.org/10.1038/onc.2011.543 2012
microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells https://doi.org/10.1158/1535-7163.MCT-12-0001 2012
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A https://doi.org/10.1002/ijc.28091 2013
"miR-200a Inhibits Tumor Proliferation by Targeting AP-2? in Neuroblastoma Cells" https://doi.org/10.7314/apjcp.2014.15.11.4671 2014
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells https://doi.org/10.3892/ol.2018.9431 2018
MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor https://doi.org/10.3892/mmr.2016.4770 2016
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 https://doi.org/10.1186/1476-4598-12-23 2013
Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis https://doi.org/10.1158/0008-5472.CAN-06-3667 2007
Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1 https://doi.org/10.3892/etm.2019.8007 2019
The MYCN oncogene is a direct target of miR-34a https://doi.org/10.1038/onc.2008.154 0
MiR-223-3p promotes the growth and invasion of neuroblastoma cell via targeting FOXO1 https://doi.org/10.26355/eurrev_201910_19298 2019
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness https://doi.org/10.1096/fj.09-134965 2009
miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo https://doi.org/10.1016/j.yexcr.2013.02.025 2013
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs https://doi.org/10.1038/onc.2012.311 2013
TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs https://doi.org/10.1038/onc.2012.490 2013
MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF) https://doi.org/10.1038/onc.2012.490 2011
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma https://doi.org/10.1093/nar/gkt346 2013
miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells https://doi.org/10.1016/j.biopha.2017.07.158 2017
miR-590-5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5 https://doi.org/10.3892/mmr.2018.9173 2018
miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1 https://doi.org/10.3892/etm.2019.7361 2019
MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells https://doi.org/10.18632/aging.101698 2019
Metastasis suppressor microRNA-335 targets the formin family of actin nucleators https://doi.org/10.1371/journal.pone.0078428 2013
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma https://doi.org/10.1002/ijc.26295 2012
Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR https://doi.org/10.1016/j.febslet.2011.10.025 2011
Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells https://doi.org/10.1016/j.jpedsurg.2012.05.013 2012
Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms. https://doi.org/10.1158/0008-5472.CAN-18-0779 2019
Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR-296-5p/Bax axis https://doi.org/10.1111/febs.15047 2019
Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway https://doi.org/10.1186/s12935-019-0968-x 2019
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma https://doi.org/10.1007/s00018-019-03041-4 2019
?-Carotene 15,15'-oxygenase inhibits cancer cell stemness and metastasis by regulating differentiation-related miRNAs in human neuroblastoma. https://doi.org/10.1016/j.jnutbio.2019.03.010 2019
Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway https://doi.org/10.1016/j.surg.2012.03.030 2013
miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis https://doi.org/10.1016/j.surg.2013.04.005 2013
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome https://doi.org/10.1038/bjc.2012.356 2012
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-? signalling pathway https://doi.org/10.1093/carcin/bgs114 2012
Exploration of human miRNA target genes in neuronal differentiation. https://doi.org/10.1093/nass/49.1.341 2005
Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line. https://doi.org/10.1016/j.jphs.2019.01.014 2019
Angelica polysaccharide exhibits antitumor effect in neuroblastoma cell line SH-SY5Y by up-regulation of miR-205 https://doi.org/10.1002/biof.1586 2019
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma https://doi.org/10.1186/1471-2407-11-33 2011
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration https://doi.org/10.1371/journal.pone.0020038 2011
MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. https://doi.org/10.1074/jbc.M112.396762 2012
Morphine modulates cell proliferation through mir133b &mir128 in the neuroblastoma SH-SY5Y cell line https://doi.org/10.1016/j.bbadis.2014.01.003 2014
Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16 https://doi.org/10.3892/or.2013.2731 2013
MicroRNA-432 contributes to dopamine cocktail and retinoic acid induced differentiation of human neuroblastoma cells by targeting NESTIN and RCOR1 genes https://doi.org/10.1016/j.febslet.2014.03.015 2014
Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma https://doi.org/10.1007/s13277-014-1921-1 2014
miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47. https://doi.org/10.18632/oncotarget.6227 2015
TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p https://doi.org/10.3892/ijo.2017.4110 2017
The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma https://doi.org/10.2147/CMAR.S196025 2019
MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma https://doi.org/10.1016/j.biopha.2016.10.008 2016
microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1 https://doi.org/10.1186/s12935-018-0551-x 2018
MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1 https://doi.org/10.3892/etm.2018.6888 2918
MicroRNA-336 directly targets Sox-2 in osteosarcoma to inhibit tumorigenesis https://doi.org/10.3892/mmr.2017.6493 2017
miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A https://doi.org/10.1016/j.febslet.2013.11.036 2014
The evolutionary young miR-1290 favors mitotic exit and differentiation of human neural progenitors through altering the cell cycle proteins https://doi.org/10.1038/cddis.2013.498 2014
MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha https://doi.org/10.1038/onc.2012.574 2014
Early targets of miR-34a in neuroblastoma https://doi.org/10.1074/mcp.M113.035808 2014
MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7 https://doi.org/10.1093/abbs/gmt124 2014
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma https://doi.org/10.1093/jnci/dju318 2014
MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression https://doi.org/10.1111/febs.12074 2013
Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors https://doi.org/10.1159/000362952 2014
A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation https://doi.org/10.18632/oncotarget.1703 2014
microRNA-202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN-5 https://doi.org/10.3892/mmr.2013.1845 2014
MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27 https://doi.org/10.7314/apjcp.2013.14.12.7081 2013
miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression https://doi.org/10.2147/OTT.S102430 2018
MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1 https://doi.org/10.1007/s13277-015-3305-6 2015
Downregulation of TrkA protein expression by miRNA-92a promotes the proliferation and migration of human neuroblastoma cells https://doi.org/10.3892/mmr.2014.2235 2014
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR-34a/cyclin D1 axis https://doi.org/10.3892/ijo.2018.4600 2019
miR-491-3p suppresses the growth and invasion of osteosarcoma cells by targeting TSPAN1 https://doi.org/10.3892/mmr.2017.7256 2017
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration https://doi.org/10.1158/1535-7163.MCT-11-0096 2011
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo https://doi.org/10.1002/1878-0261.12015 2017
MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b. https://doi.org/10.1038/modpathol.2016.177 2017
MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells. https://doi.org/10.1007/s12031-015-0548-z 2015
MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells https://doi.org/10.1093/abbs/gms019 2012
MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1 https://doi.org/10.1159/000472380 2017
Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells https://doi.org/10.1074/mcp.M114.041905 2015
MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas. https://doi.org/10.18632/oncotarget.25563 2018
MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68 https://doi.org/10.3892/mmr.2015.4013 2015
miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14 https://doi.org/10.18632/oncotarget.4311 2015
0
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin https://doi.org/10.1002/ijc.29091 2015
Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f https://doi.org/10.1002/ijc.29144 2015
miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14 https://doi.org/10.1016/j.bbadis.2015.06.002 2015
miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells https://doi.org/10.1016/j.bbagrm.2015.06.008 2015
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis https://doi.org/10.1016/j.ccell.2015.09.012 2015
miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2? https://doi.org/10.1016/j.febslet.2015.05.056 2015
High-throughput microRNA profiling of pediatric high-grade gliomas. https://doi.org/10.1093/neuonc/not215 2014
Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138. https://doi.org/10.1002/jcb.27307 2018
A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells. https://doi.org/10.1074/jbc.M114.616748 2014
Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31. https://doi.org/10.1002/jcb.26716 2018
Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors. https://doi.org/10.1093/carcin/bgu105 2014
Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation https://doi.org/10.1016/j.molonc.2015.03.005 2015
Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas https://doi.org/10.18632/oncotarget.7736 2016
Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients https://doi.org/10.18632/oncotarget.3745 2015
Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma https://doi.org/10.1038/srep09027 2015
MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. https://doi.org/10.1371/journal.pone.0010748 2010
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation https://doi.org/10.1038/s41598-018-32195-7 2018
miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10 https://doi.org/10.1016/j.biopha.2018.04.153 2018
Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma https://doi.org/10.21873/cgp.20100 2018
MicroRNA-664a-5p promotes neuronal differentiation of SH-SY5Y cells https://doi.org/10.1111/gtc.12559 2018
MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma https://doi.org/10.1186/s40659-018-0162-y 2018
microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi https://doi.org/10.1371/journal.pone.0208777 2018
Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression https://doi.org/10.1002/jcp.28017 2019
LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases https://doi.org/10.1080/15384047.2018.1550568 2019
Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma https://doi.org/10.3389/fonc.2019.00459 2019
Silencing CASC11 curbs neonatal neuroblastoma progression through modulating microRNA-676-3p/nucleolar protein 4 like (NOL4L) axis https://doi.org/10.1038/s41390-019-0625-z 2019
miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1 https://doi.org/10.2147/OTT.S205582 2019
LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma https://doi.org/10.26355/eurrev_201910_19296 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma https://doi.org/10.1002/1878-0261.12588 2019
SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3?-mediated activation of Wnt/?-catenin signaling https://doi.org/10.1002/2211-5463.12594 2019
microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest https://doi.org/10.1080/15476286.2015.1023495 2015
Identification of linc-NeD125, a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells https://doi.org/10.1080/15476286.2015.1096488 2015
Suppression of miR-19b enhanced the cytotoxic effects of mTOR inhibitors in human neuroblastoma cells https://doi.org/10.1016/j.jpedsurg.2016.07.003 2016
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma https://doi.org/10.18632/oncotarget.13090 2016
ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State https://doi.org/10.1158/1541-7786.MCR-19-0187 2019
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma https://doi.org/10.1177/1176935119832910 2019
FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-?1 induced LMO1 via control of let-7 expression https://doi.org/10.1016/j.brainres.2018.10.015 2019
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression https://doi.org/10.1038/aps.2015.153 2016
miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor https://doi.org/10.7314/apjcp.2015.16.11.4509 2015
miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3? and SFRP1 https://doi.org/10.1016/j.biopha.2016.07.010 2016
miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity https://doi.org/10.3892/mmr.2017.6187 2017
miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion https://doi.org/10.3892/ol.2017.7432 2018
microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma https://doi.org/10.1177/1535370214563893 2015
LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-? pathway by sponging miR-185-5p https://doi.org/10.1016/j.bbrc.2019.10.136 2019
Nucleotidyl transferase TUT1 inhibits lipogenesis in osteosarcoma cells through regulation of microRNA-24 and microRNA-29a https://doi.org/10.1007/s13277-014-2395-x 2014
Silencing of SNHG6 induced cell autophagy by targeting miR-26a-5p/ULK1 signaling pathway in human osteosarcoma https://doi.org/10.1186/s12935-019-0794-1 2019
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients https://doi.org/10.1016/j.celrep.2016.06.052 2016
Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138 PMID:?26823826 2015
Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo https://doi.org/10.1159/000430220 2015
Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis https://doi.org/10.1080/2162402X.2017.1333214 2017
Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134 https://doi.org/10.1002/jcb.28003 2018
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling https://doi.org/10.1093/carcin/bgt065 2013
Minichromosome Maintenance Complex Is a Critical Node in the miR-183 Signaling Network of MYCN-Amplified Neuroblastoma Cells https://doi.org/10.1021/acs.jproteome.6b00134 2016
Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis https://doi.org/10.2147/CMAR.S222708 2019
Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo https://doi.org/10.1111/cas.12436 2014
A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma https://doi.org/10.3892/or.2017.5701 2017
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma https://doi.org/10.1186/s12885-017-3340-3 2017
WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner https://doi.org/10.3390/ijms20205235 2019
Dexmedetomidine Inhibits Osteosarcoma Cell Proliferation and Migration, and Promotes Apoptosis by Regulating miR-520a-3p https://doi.org/10.3727/096504017X14982578608217 2018
Honokiol suppresses proliferation and induces apoptosis via regulation of the miR-21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells https://doi.org/10.3892/ijmm.2018.3433 2018
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes https://doi.org/10.18632/oncotarget.7005 2016
Procaine Inhibits Proliferation and Migration and Promotes Cell Apoptosis in Osteosarcoma Cells by Upregulation of MicroRNA-133b https://doi.org/10.3727/096504017X14878518291077 2017
Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221 https://doi.org/10.1155/2016/7319464 2016
Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR-183/Ezrin pathway https://doi.org/10.3892/mmr.2018.9036 2018
Decreased expression of tumor suppressive miR-874 and its clinical significance in human osteosarcoma https://doi.org/10.4238/2015.December.23.19 2015
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth https://doi.org/10.1016/j.bcp.2015.10.015 2015
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1 https://doi.org/10.1007/s13277-015-4187-3 2016
miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61 https://doi.org/10.1159/000495396 2018
p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-?1 https://doi.org/10.1002/mc.22299 2016
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma https://doi.org/10.1002/mc.22753 2018
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas https://doi.org/10.18632/oncotarget.3088 2015
miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma https://doi.org/10.3349/ymj.2019.60.9.832 2019
Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis https://doi.org/10.14348/molcells.2015.0037 2015
A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells https://doi.org/10.18632/oncotarget.12676 2016
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas https://doi.org/10.18632/oncotarget.7434 2016
microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma https://doi.org/10.18632/oncotarget.9813 2016
microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma https://doi.org/https://doi.org/10.18632/oncotarget.9813 2016
miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase https://doi.org/10.1093/hmg/ddv018 2015
MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma https://doi.org/10.1371/journal.pone.0078713 2013
MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines https://doi.org/10.3892/or.2016.4640 2016
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells https://doi.org/10.3892/or.2016.4676 2016
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways https://doi.org/10.1158/0008-5472.CAN-17-0454 2018
17?-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner https://doi.org/10.1016/j.bbrc.2014.12.114 2015
Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies https://doi.org/10.22074/cellj.2019.6008 2019
A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival https://doi.org/10.1038/s41556-017-0006-y 2018
Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma https://doi.org/10.1371/journal.pone.0202896 2018
microRNA-494 Favors HO-1 Expression in Neuroblastoma Cells Exposed to Oxidative Stress in a Bach1-Independent Way https://doi.org/10.3389/fonc.2018.00199 2018
Angelica sinensis polysaccharide inhibits proliferation, migration, and invasion by downregulating microRNA-675 in human neuroblastoma cell line SH-SY5Y https://doi.org/10.1002/cbin.10954 2018
The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA) https://doi.org/10.1007/s12031-018-1118-y 2018
Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells https://doi.org/10.18632/oncotarget.26534 2019
Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas https://doi.org/10.33594/000000134 2019
A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma https://doi.org/10.18632/oncotarget.17033 2017
microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma https://doi.org/10.1158/1078-0432.CCR-16-1591 2017
miR-506 suppresses neuroblastoma metastasis by targeting ROCK1 https://doi.org/10.3892/ol.2016.5442 2017
Discovering cancer vulnerabilities using high-throughput micro-RNA screening https://doi.org/10.1093/nar/gkx1072 2017
Reciprocal antagonistic regulation of N-myc mRNA by miR-17 and the neuronal-specific RNA-binding protein HuD https://doi.org/10.3892/or.2017.5664 2017
Induction of morphological and functional differentiation of human neuroblastoma cells by miR-124 https://doi.org/10.1007/s12038-017-9714-5 2017
The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity https://doi.org/10.1371/journal.pone.0128472 2015
Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1 https://doi.org/10.1111/jcmm.14123 2019
MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4B(DCAF13) E3 Ligase in Osteosarcoma Cells https://doi.org/10.1016/j.omtn.2017.12.010 2018
Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4 https://doi.org/10.3892/ol.2017.6052 2017
MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase https://doi.org/10.1007/s13277-013-1546-9 2014
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers https://doi.org/10.1158/0008-5472.CAN-09-3875 2010
Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA https://doi.org/10.4149/neo_2013_050 2013
MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS) https://doi.org/10.3233/CBM-170577 2017
MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification https://doi.org/10.1016/j.biochi.2017.04.011 2017
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness https://doi.org/10.1002/jcp.24272 2013
Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137 https://doi.org/10.1016/j.ejphar.2017.02.035 2017
Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma https://doi.org/10.1007/s12253-017-0316-1 2019
miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts https://doi.org/10.1002/1878-0261.12154 2018
miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1 https://doi.org/10.3727/096504017X14974834436195 2018
miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A https://doi.org/10.1016/j.mehy.2018.05.019 2018
MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling https://doi.org/10.1073/pnas.1710901115 2018
Inhibition of JAK1 by microRNA-708 promotes SH-SY5Y neuronal cell survival after oxygen and glucose deprivation and reoxygenation. https://doi.org/10.1016/j.neulet.2017.11.017 2018
MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1 https://doi.org/10.1002/mc.22839 2018
Exogenous expression of miRNA-3613-3p causes APAF1 downregulation and affects several proteins involved in apoptosis in BE(2)-C human neuroblastoma cells https://doi.org/10.3892/ijo.2018.4509 2018
Lin28B and miR-142-3p regulate neuronal differentiation by modulating Staufen1 expression https://doi.org/10.1038/cdd.2017.182 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN https://doi.org/10.1158/0008-5472.CAN-17-3034 2018
MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN https://doi.org/10.18632/oncotarget.24793 2018
Differentiation Induces Dramatic Changes in miRNA Profile, Where Loss of Dicer Diverts Differentiating SH-SY5Y Cells Toward Senescence https://doi.org/10.1007/s12035-016-0042-9 2017
Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a https://doi.org/10.3727/096504018X15179661552702 2018
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis https://doi.org/10.18632/aging.102325 2019
MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3 https://doi.org/10.21873/cgp.20113 2019
miR-22 promotes apoptosis of osteosarcoma cells via inducing cell cycle arrest https://doi.org/10.3892/ol.2017.5674 2017
Inhibition of miR-9 decreases osteosarcoma cell proliferation https://doi.org/10.17305/bjbms.2019.4434 2019
MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo https://doi.org/10.3892/ol.2016.4162 2016
MicroRNA-874-mediated inhibition of the major G(1)/S phase cyclin, CCNE1, is lost in osteosarcomas https://doi.org/10.1074/jbc.M117.808287 2017
MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway https://doi.org/10.4149/BLL_2017_087 2017
Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis https://doi.org/10.1016/j.bbrc.2017.11.121 2018
Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells https://doi.org/10.1158/1535-7163.MCT-12-0869 2013
MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma https://doi.org/10.1038/cgt.2015.27 2015
MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells https://doi.org/10.1042/BSR20140084 2014
Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication https://doi.org/10.1371/journal.pone.0166027 2016
Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication https://doi.org/10.1371/journal.pone.0166027- 2016
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells https://doi.org/10.1371/journal.pone.0161023 2016
HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1 https://doi.org/10.1002/jcp.27394 2019
MicroRNA-155 targets MAP3K10 and regulates osteosarcoma cell growth https://doi.org/10.1016/j.prp.2016.12.028 2017
MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1 https://doi.org/10.1080/09168451.2019.1569496 2019
FOXO1-MALAT1-miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma Cells https://doi.org/10.3727/096504017X14859934460780 2017
CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling https://doi.org/10.1016/j.canlet.2017.01.013 2017
microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6 https://doi.org/10.1007/s13277-014-3034-2 2015
miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway https://doi.org/10.1089/cbr.2017.2306 2018
MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion https://doi.org/10.1007/s13277-014-2600-y 2014
MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells https://doi.org/10.1177/1533034615601563 2016
Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell https://doi.org/10.1002/jcb.26230 2018
LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a https://doi.org/10.1159/000487178 2018
MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression https://doi.org/?10.1016/j.prp.2018.10.012. 2019
A sensitive switch for visualizing natural gene silencing in single cells https://doi.org/10.1021/sb3000035 2012
Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts https://doi.org/10.3892/ol.2012.866. 2012
Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts https://doi.org/10.3892/ol.2012.866 2012
MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27 https://doi.org/10.1002/jcb.27755 2019
Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis https://doi.org/10.1016/j.gene.2019.06.005 2019
Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a https://doi.org/10.1111/cpr.12409 2018
Roles of microRNA-206 in osteosarcoma pathogenesis and progression https://doi.org/10.7314/apjcp.2013.14.6.3751 2013
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis https://doi.org/10.1016/j.molonc.2016.04.004 2016
Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1 https://doi.org/10.4103/0973-1482.191635 2016
Knockdown of Long Noncoding RNA CAT104 Inhibits the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells by Regulating MicroRNA-381 https://doi.org/10.3727/096504018X15199511344806 2018
MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2 https://doi.org/10.1042/BSR20160542 2017
Tumor-suppressing effects of miR-141 in human osteosarcoma https://doi.org/10.1007/s12013-013-9801-7 2014
Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p https://doi.org/10.1016/j.gene.2019.144145 2019
Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model https://doi.org/10.1186/s12920-015-0106-0 2015
PCAF regulates H3 phosphorylation and promotes autophagy in osteosarcoma cells https://doi.org/10.1016/j.biopha.2019.109395 2019
lncRNA C2dat1 Promotes Cell Proliferation, Migration, and Invasion by Targeting miR-34a-5p in Osteosarcoma Cells https://doi.org/10.3727/096504017X15024946480113 2018
CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells https://doi.org/10.18632/oncotarget.6708 2016
Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma https://doi.org/10.1159/000481650 2017
MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway https://doi.org/10.1002/jcb.27929 2019
MicroRNA-300 decreases cell viability, inhibits migration and promotes apoptosis of osteosarcoma cells via downregulation of Twist1 https://doi.org/10.3892/mmr.2017.7023 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models https://doi.org/10.18632/oncotarget.16372 2017
MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate https://doi.org/10.3892/ol.2015.3790 2015
Identification of miR-200c-3p as a major regulator of SaoS2 cells activation induced by fluoride https://doi.org/10.1016/j.chemosphere.2018.01.095 2018
microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases https://doi.org/10.1038/s41598-017-06553-w 2017
Extracellular Nanovesicles Secreted by Human Osteosarcoma Cells Promote Angiogenesis https://doi.org/10.3390/cancers11060779 2019
HSP90 regulates osteosarcoma cell apoptosis by targeting the p53/TCF-1-mediated transcriptional network https://doi.org/10.1002/jcp.29283 2019
Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines https://doi.org/10.1371/journal.pone.0043720 2012
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells https://doi.org/10.1093/nar/gkv1500 2016
MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells https://doi.org/10.3892/ol.2015.3581 2015
Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells https://doi.org/10.18632/oncotarget.12712 2016
Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype https://doi.org/10.1371/journal.pone.0044001 2012
MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy https://doi.org/10.3892/or.2015.4497 2016
MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin https://doi.org/10.3892/ijo.2014.2641 2014
MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase https://doi.org/10.3727/096504017X14850134190255 2017
Downregulation of microRNA-586 Inhibits Proliferation, Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line https://doi.org/10.1159/000441073 2015
LncRNA SPRY4-IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR-101 activity https://doi.org/10.3892/ijo.2019.4910 2019
MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell https://doi.org/10.1007/s13277-013-0902-0 2013
MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells https://doi.org/10.1691/ph.2017.6921 2017
MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3 https://doi.org/10.18632/oncotarget.14184 2017
Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR-122 in osteosarcoma https://doi.org/10.1002/jcb.26273 2018
Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN https://doi.org/10.3892/etm.2017.5477 2018
Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma https://doi.org/10.1159/000343336 2012
Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro https://doi.org/10.1016/j.prp.2019.01.042 2019
Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182 https://doi.org/10.1159/000495493 2018
Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2 https://doi.org/10.1080/15384101.2019.1618127 2019
MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-?-mediated AKT/GSK-3?/SNAIL-1 signaling https://doi.org/10.3892/mmr.2018.8637 2018
MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating Ezrin https://doi.org/10.3892/ol.2016.5046 2016
LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway https://doi.org/10.1016/j.biopha.2018.07.119 2018
MicroRNA-143 promotes apoptosis of osteosarcoma cells by caspase-3 activation via targeting Bcl-2 https://doi.org/10.1016/j.biopha.2016.03.001 2016
MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma https://doi.org/10.1159/000437379 2015
MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells https://doi.org/10.4149/neo_2014_034 2014
MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells https://doi.org/10.3892/ol.2016.5172 2016
miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells https://doi.org/10.1016/j.bbrc.2016.02.050 2016
Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells https://doi.org/10.1016/j.bbrc.2015.04.013 2015
MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression https://doi.org/10.2147/OTT.S194800 2019
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1 https://doi.org/10.12659/msm.896451 2016
Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo https://doi.org/10.3892/mmr.2015.3880 2015
MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling https://doi.org/10.3892/or.2015.4186 2015
MicroRNA-210 is increased and it is required for dedifferentiation of osteosarcoma cell line https://doi.org/10.1002/cbin.10721 2017
Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo https://doi.org/10.1111/cas.12436 2014
MiR-598: A tumor suppressor with biomarker significance in osteosarcoma https://doi.org/10.1016/j.lfs.2017.09.003 2017
Long non-coding RNA LINC00152 promotes tumorigenesis via sponging miR-193b-3p in osteosarcoma https://doi.org/10.3892/ol.2019.10700 2019
Upregulation of miR-95-3p inhibits growth of osteosarcoma by targeting HDGF https://doi.org/10.1016/j.prp.2019.152492 2019
MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma https://doi.org/10.3727/096504016X14813867762123 2017
MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4 https://doi.org/10.3892/ijo.2015.3147 2015
MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway https://doi.org/10.1007/s13277-016-4807-6 2016
MicroRNA sponge blocks the tumor-suppressing functions of microRNA-122 in human hepatoma and osteosarcoma cells https://doi.org/10.3892/or.2014.3517 2014
microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN https://doi.org/10.3892/ol.2012.863 2012
MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6 https://doi.org/10.1177/1010428317744704 2018
Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas https://doi.org/10.1038/srep28953 2016
MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells https://doi.org/10.1159/000356679 2014
How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation https://doi.org/10.1371/journal.pcbi.1003210 2013
Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion https://doi.org/10.1002/jcp.29351 2019
MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1 https://doi.org/10.3892/or.2015.3986 2015
Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression https://doi.org/10.4149/BLL_2018_009 2018
MicroRNA-340-5p modulates cisplatin resistance by targeting LPAAT? in osteosarcoma https://doi.org/10.1590/1414-431X20176359 2017
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAAT?/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p https://doi.org/10.1002/jcb.28244 2019
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway https://doi.org/10.1016/j.prp.2018.12.013 2019
Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells https://doi.org/10.1371/journal.pone.0079231 2013
Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs). https://doi.org/10.3390/ijms18122742 2017
MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression https://doi.org/10.3892/or.2014.3459 2014
Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599 https://doi.org/10.1038/s41434-019-0112-5 2019
Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21 https://doi.org/10.1002/jcb.26671 2018
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest https://doi.org/10.1038/srep26611 2016
Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN https://doi.org/10.1186/s12920-017-0300-3 2017
MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma https://doi.org/10.1002/iub.1753 2018
MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1 https://doi.org/10.3892/ol.2018.8180 2018
miR-23b-3p suppressing PGC1? promotes proliferation through reprogramming metabolism in osteosarcoma https://doi.org/10.1038/s41419-019-1614-1 2019
MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma https://doi.org/10.3892/mmr.2016.5741 2016
MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line https://doi.org/10.1007/s11845-014-1225-x 2016
IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma https://doi.org/10.1007/s10735-016-9659-2 2016
miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb https://doi.org/10.3892/ol.2018.8761 2018
miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1 https://doi.org/10.3389/fgene.2015.00233 2015
LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5 https://doi.org/10.1016/j.biopha.2018.04.193 2018
miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy https://doi.org/10.1007/s13277-014-1965-2 2014
miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1 https://doi.org/10.1186/s12935-017-0398-6 2017
miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2 https://doi.org/10.3892/or.2019.7078 2019
miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression https://doi.org/10.1158/0008-5472.CAN-11-1460 2012
Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity https://doi.org/10.1158/1541-7786.MCR-13-0292 2013
Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells https://doi.org/10.3892/ijo.2015.2867 2015
miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors https://doi.org/10.18632/oncotarget.10950 2016
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate https://doi.org/10.1186/1477-7819-12-383 2014
p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway https://doi.org/10.1042/BSR20181268 2019
Overexpression of microRNA-448 inhibits osteosarcoma cell proliferation and invasion through targeting of astrocyte elevated gene-1 https://doi.org/10.3892/mmr.2017.7249 2017
microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells https://doi.org/10.1186/s13046-015-0192-z 2015
MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4 https://doi.org/10.1186/s12885-018-4460-0 2018
miR-15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl-2 expression in human osteosarcoma cells https://doi.org/10.3892/ijo.2018.4285 2018
Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a https://doi.org/10.1080/15384047.2018.1538612 2019
H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma https://doi.org/10.1089/dna.2015.3171 2016
miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal https://doi.org/10.3233/CBM-170452 2017
MiR-374a Activates Wnt/?-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1 https://doi.org/10.1007/s12253-018-0556-8 2018
Circ_ORC2 enhances the regulatory effect of miR-19a on its target gene PTEN to affect osteosarcoma cell growth https://doi.org/10.1016/j.bbrc.2019.04.188 2019
miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy https://doi.org/10.1007/s13277-014-1797-0 2014
The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells https://doi.org/10.1155/2019/7028901 2019
TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma https://doi.org/10.1007/s00432-015-2028-9 2016
Long non-coding RNA ZFAS1 regulates NOB1 expression through interacting with miR-646 and promotes tumorigenesis in osteosarcoma https://doi.org/10.26355/eurrev_201904_17679 2019
miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1 https://doi.org/10.3892/ijo.2018.4275 2018
Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase https://doi.org/10.3892/etm.2013.959 2013
MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-?B signaling pathway https://doi.org/10.26355/eurrev_201811_16380 2018
MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/EMT pathway https://doi.org/10.26355/eurrev_201906_18040 2019
miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells https://doi.org/10.3892/etm.2014.1942 2014
miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66 https://doi.org/10.1177/1533033819870209 2019
MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma https://doi.org/10.1002/ijc.32368 2019
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression https://doi.org/10.1371/journal.pone.0114757 2014
miR-196a expression in human and canine osteosarcomas: a comparative study https://doi.org/10.1016/j.rvsc.2014.12.017 2015
MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene https://doi.org/10.1186/s12935-016-0340-3 2016
MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively https://doi.org/10.1007/s10585-016-9783-0 2016
MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene https://doi.org/10.18632/oncotarget.8546 2016
MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene https://doi.org/10.1038/srep44218 2017
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene https://doi.org/10.1186/s12885-016-3002-x 2017
MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1 https://doi.org/10.1002/cbin.10723 2017
Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs https://doi.org/10.1093/carcin/bgz130 2019
MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis https://doi.org/10.1002/jcp.26923 2018
miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression https://doi.org/10.3892/ol.2017.7364 2018
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells https://doi.org/10.18632/oncotarget.3025 2015
MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN https://doi.org/10.1007/s13277-013-1274-1 2014
MicroRNA-211-5p promotes the apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11 https://doi.org/10.1139/bcb-2018-0380 2019
Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration https://doi.org/10.1016/j.bbrc.2014.02.007 2014
miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin https://doi.org/10.1016/j.bbrc.2018.02.091 2018
MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16 https://doi.org/https://doi.org/10.1159/000438575 2015
MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. https://doi.org/10.1097/FPC.0000000000000245 2016
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia. https://doi.org/10.1097/FPC.0000000000000291 2017
Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia https://doi.org/10.1371/journal.pone.0091261 2014
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia. https://doi.org/10.1038/s41397-017-0003-3 2018
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity. https://doi.org/10.2217/epi-2017-0138 2018
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis https://doi.org/10.1007/s00381-008-0701-x 2009
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways https://doi.org/10.1371/journal.pone.0056334 2013
Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis https://doi.org/10.1038/leu.2017.73 2017
Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia https://doi.org/10.1038/leu.2013.49 2013
Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases https://doi.org/10.22034/APJCP.2018.19.8.2263 2018
Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors. https://doi.org/10.1186/s12885-019-5739-5 2019
Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia. https://doi.org/ 10.1016/j.cancergen.2016.09.009 2016
Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children. https://doi.org/10.3109/10428194.2015.1092528 2015
A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma https://doi.org/10.3233/cbm-160248 2017
A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report https://doi.org/10.1007/s13277-013-1027-1 2014
Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia https://doi.org/10.1038/leu.2011.105 2011
Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children. https://doi.org/10.1016/j.mrfmmm.2013.11.004 2014
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk. https://doi.org/10.18632/oncotarget.25144 2017
Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia. https://doi.org/10.1158/0008-5472.CAN-12-4367 2013
Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility. https://doi.org/10.1038/pr.2014.43 2014
Identification of microRNAs as potential prognostic markers in ependymoma. https://doi.org/10.1371/journal.pone.0025114 2011
Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers https://doi.org/10.1016/j.tranon.2019.06.008 2019
miR-34b/c rs4938723 T>C Decreases Neuroblastoma Risk: A Replication Study in the Hunan Children https://doi.org/10.1155/2019/6514608 2019
Association of miR-146a, miR-149 and miR-196a2 polymorphisms with neuroblastoma risk in Eastern Chinese population: a three-center case-control study https://doi.org/10.1042/BSR20181907 2019
MicroRNA profiles in neuroblastoma: Differences in risk and histology groups https://doi.org/10.1111/ajco.12821 2018
Association of Common Genetic Variants in Pre-microRNAs and Neuroblastoma Susceptibility: A Two-Center Study in Chinese Children https://doi.org/10.1016/j.omtn.2018.01.003 2018
MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. https://doi.org/10.1002/gcc.20776 2010
miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia https://doi.org/10.1002/gcc.22334 2015
T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases. https://doi.org/10.1002/gcc.22423 2016
T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases. https://doi.org/10.1002/gcc.22423 2016
miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias. https://doi.org/10.1186/1476-4598-13-175 2015
MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor. https://doi.org/10.1016/j.jsbmb.2017.05.014 2017
Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. https://doi.org/10.1016/j.leukres.2008.12.015 2009
Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia https://doi.org/10.1155/2014/967585 2014
Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia https://doi.org/10.1002/pbc.23279 2012
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways https://doi.org/10.1371/journal.pone.0056334 2013
Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia https://doi.org/10.2147/OTT.S36017 2012
High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia https://doi.org/10.3892/or.2015.3787 2015
MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia https://doi.org/10.1186/1475-2867-13-110 2013
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment https://doi.org/10.18632/oncotarget.10577 2016
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma https://doi.org/10.4161/cc.8.1.7292 2009
Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma https://doi.org/10.1016/j.bbrc.2010.08.015 2010
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group https://doi.org/10.1158/1078-0432.CCR-10-0091 2011
miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM https://doi.org/10.1007/s00432-015-1995-1 2016
Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1 https://doi.org/10.1186/1476-4598-13-123 2014
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma https://doi.org/10.3390/cancers11091380 2019
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors https://doi.org/10.1158/0008-5472.CAN-09-3970 2010
MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance https://doi.org/10.1097/MPH.0000000000001234 2019
MicroRNA expression might predict prognosis of epithelial hepatoblastoma https://doi.org/10.1007/s00428-014-1549-y 2014
Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo https://doi.org/10.1080/21691401.2019.1664561 2019
Altered microRNA Expression Patterns in Hepatoblastoma Patients https://doi.org/10.1593/tlo.09124 2009
Solid tumors of childhood display specific serum microRNA profiles https://doi.org/10.1158/1055-9965.EPI-14-0669 2015
Solid tumors of childhood display specific serum microRNA profiles https://doi.org//10.1158/1055-9965.EPI-14-0669 2015
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group https://doi.org/10.1002/pbc.26157 2016
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome https://doi.org/10.1182/blood-2014-06-581892 2015
MiR-10b regulates the proliferation and apoptosis of pediatric acute myeloid leukemia through targeting HOXD10 https://doi.org/10.26355/eurrev_201811_16275 2018
MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia https://doi.org/10.1007/s00432-016-2277-2 2017
Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia https://doi.org/10.1007/s11010-013-1754-z 2013
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia https://doi.org/10.1111/bjh.14950 2018
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia https://doi.org/10.1186/1476-4598-10-108 2011
MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia https://doi.org/10.1371/journal.pone.0007826 2009
Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children https://doi.org/10.3892/etm.2019.7643 2019
Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway https://doi.org/10.1002/jcb.25999 2017
Circulating serum miRNAs as potential biomarkers for nephroblastoma https://doi.org/10.1002/pbc.25481 2015
MicroRNA-197 Mediates the Overgrowth and Anti-Apoptotic Effects by Downregulating Insulin-Like Growth Factor-Binding Protein-3 During Nephroblastoma Tumorigenesis. https://doi.org/10.1080/15513815.2016.1178360 2016
miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema. https://doi.org/10.1371/journal.pone.0053417 2013
The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis https://doi.org/10.1101/gad.224170.113 2013
Aberrant Expression of Some Circulating miRNAs in Childhood Acute Lymphoblastic Leukemia " https://doi.org/10.1007/s10528-018-9844-y 2018
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia. https://doi.org/10.1186/s12967-019-2114-x 2019
Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia. https://doi.org/10.1007/s13277-016-4948-7 2016
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia https://doi.org/10.1007/s00277-018-3292-y 2018
Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes https://doi.org/10.3390/ijms17040475 2016
Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour https://doi.org/10.1186/s12920-019-0644-y 2019
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor https://doi.org/10.1038/ng.3940 2017
Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia https://doi.org/10.1080/08880010802378338 2009
High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome https://doi.org/10.17179/excli2016-707 2017
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation https://doi.org/10.1186/s12885-015-1661-7 2015
Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia. https://doi.org/10.1016/j.neo.2019.01.004 2019
Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing. https://doi.org/10.1038/s41598-017-08148-x 2017
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia https://doi.org/10.18632/oncotarget.10270 2016
Onco-microRNA miR-130b promoting cell growth in children APL by targeting PTEN https://doi.org/10.1016/j.apjtm.2016.01.024 2016
MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia. https://doi.org/10.1002/hon.2567 2019
Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia. https://doi.org/10.1007/s12253-014-9861-z 2014
Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features https://doi.org/10.1016/j.leukres.2011.10.005 2012
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. https://doi.org/10.1038/leu.2009.208 2010
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. https://doi.org/10.3324/haematol.2010.023481 2010
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia. https://doi.org/10.18632/oncotarget.16392 2017
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia https://doi.org/10.3324/haematol.2010.026138 2011
miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2. https://doi.org/10.3727/096504016X14597766487753 2016
MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features https://doi.org/10.1002/pbc.25222 2015
miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia. https://doi.org/10.1002/jcb.27918 2018
Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia. https://doi.org/10.3892/ol.2017.6599 2017
In vitro knock-out of miR-155 suppresses leukemic and HCV virus loads in pediatric HCV-4-associated acute lymphoid leukemia: A promising target therapy. https://doi.org/10.1002/jcb.29512 2019
Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia. https://doi.org/10.1080/10245332.2017.1292204 2017
Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children https://doi.org/10.12659/msm.897417 2016
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma https://doi.org/10.1002/gcc.10316 2004
miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis https://doi.org/10.1007/s00277-016-2653-7 2016
Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma. https://doi.org/10.1002/gcc.22467 2017
Upregulation of miR-20a and miR-106b is involved in the acquisition of malignancy of pediatric brainstem gliomas. https://doi.org/10.3892/or.2012.1927 2012
Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma. https://doi.org/10.3892/mmr.2017.6490 2017
Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma. https://doi.org/10.1007/s12094-018-1876-6 2018
Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. https://doi.org/10.1371/journal.pone.0023935 2011
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma https://doi.org/10.1186/1471-2407-9-441 2009
The miR-17-92 microRNA cluster regulates multiple components of the TGF-? pathway in neuroblastoma https://doi.org/10.1016/j.molcel.2010.11.038 2010
Association of microRNA 21 With Biological Features and Prognosis of Neuroblastoma https://doi.org/10.1177/107327481602300113 2016
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples https://doi.org/10.1158/1078-0432.CCR-11-0610 2011
Extension of microRNA expression pattern associated with high-risk neuroblastoma https://doi.org/10.1007/s13277-013-0777-0 2013
Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms. https://doi.org/10.1186/s13045-014-0096-y 2014
miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas https://doi.org/10.1007/s13277-016-4903-7 2016
Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-kappaB pathways. https://doi.org/10.1186/s40478-015-0266-3 2015
PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis https://doi.org/10.1007/s00381-017-3366-5 2017
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients https://doi.org/10.1002/cam4.264 2014
Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. https://doi.org/10.1007/s00381-009-1028-y 2009
Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume. https://doi.org/10.1007/s00701-018-3589-6 2018
MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading https://doi.org/10.3892/ol.2018.9685 2018
Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures- https://doi.org/10.18632/oncotarget.23311 2017
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation https://doi.org/10.3892/mco.2019.1795 2019
Circulating microRNAs as Biomarkers for Pediatric Astrocytomas. https://doi.org/10.1016/j.arcmed.2017.07.002 2017
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. https://doi.org/10.1007/s11060-018-03042-6 2018
Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. https://doi.org/10.1186/1746-1596-8-158 2013
Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. https://doi.org/10.1002/ijc.29610 2015
Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors. https://doi.org/10.1186/s12920-015-0103-3 2015
A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. https://doi.org/10.1016/j.jprot.2013.09.009 2013
A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. https://doi.org/j.jprot.2013.09.009 2013
Extensive miRNA expression analysis in craniopharyngiomas. https://doi.org/10.1007/s00381-016-3131-1 2016
Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma. https://doi.org/10.1371/journal.pone.0158464 2016
Survey of MicroRNA Expression in Pediatric Brain Tumors https://doi.org/10.1002/pbc.22723 2011
Identification of microRNAs as potential prognostic markers in ependymoma. https://doi.org/journal.pone.0025114 2011
Identification of microRNA signature in different pediatric brain tumors. https://doi.org/10.1590/1678-4685-GMB-2016-0334 2018
miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children https://doi.org/10.18632/oncotarget.24874 2019
Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas https://doi.org/10.3760/cma.j.issn.0366-6999.2009.20.002 2009
miR-141-3p and TRAF5 Network Contributes to the Progression of T-Cell Acute Lymphoblastic Leukemia. https://doi.org/10.1177/0963689719887370 2019
MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma https://doi.org/10.3892/ol.2015.3378 2015
Clinical significance of microRNA-34b expression in pediatric acute leukemia https://doi.org/10.3892/mmr.2016.4876 2016
Differentially expressed miRNAs in retinoblastoma https://doi.org/10.1016/j.gene.2012.09.129 2013
MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia https://doi.org/10.26355/eurrev_201910_19159 2019
Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p https://doi.org/hsa-mir-488-3p 2019
Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia https://doi.org/10.3233/CBM-170327 2018
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting ?-catenin and Wnt signaling https://doi.org10.1002/hep4.1029 2017
Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study https://doi.org/10.1016/j.jpedsurg.2016.02.091 2016
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation https://doi.org/10.3324/haematol.2012.070664 2013
MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA https://doi.org/10.26355/eurrev_201906_18202 2019
Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential https://doi.org/10.1016/j.prp.2017.06.017 2017
Prognostic value of miR-29a expression in pediatric acute myeloid leukemia https://doi.org/10.1016/j.clinbiochem.2012.09.002 2013
MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk. https://doi.org/10.1002/kjm2.12180 2019
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization https://doi.org/10.1371/journal.pone.0052397 2012
Identification of the transcription factor HOXB4 as a novel target of miR-23a https://doi.org/10.1002/gcc.22066 2013
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. https://doi.org/10.1093/carcin/bgs126 2012
Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. https://doi.org/10.1016/j.gene.2019.01.003 2019
MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia https://doi.org/10.4161/auto.29592 2014
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. https://doi.org/10.1111/j.1365-2141.2011.08812.x 2011
Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia https://doi.org/10.3233/CBM-170657 2018
Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia. https://doi.org/10.1097/MPH.0000000000000921 2017
Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia. https://doi.org/10.1111/cas.12370 2014
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. https://doi.org/10.1158/0008-5472.CAN-08-4025 2009
Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia. https://doi.org/10.3892/ol.2017.7229 2017
MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools https://doi.org/10.3109/10428194.2012.685731 2012
Genome-wide analysis of small RNA and novel MicroRNA discovery in human acute lymphoblastic leukemia based on extensive sequencing approach. https://doi.org/10.1371/journal.pone.0006849 2009
MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia. https://doi.org/10.1016/j.gene.2017.07.052 2017
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment https://doi.org/10.1038/bjc.2017.256 2017
The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia. https://doi.org/10.2147/CMAR.S214405 2019
MicroRNA-31 is a potential biomarker for screening B-lymphoblastic leukemia in children. https://doi.org/10.3892/ol.2019.10843 2019
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles https://doi.org/10.1002/ijc.25436 2010
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma https://doi.org/10.1038/bjc.2011.388 2011
Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican https://doi.org/10.1007/s00381-014-2416-5 2014
MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors. https://doi.org/10.3727/096368914X678364 2014
Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis https://doi.org/10.1002/gcc.22189 2014
Extensive miRNA expression analysis in craniopharyngiomas. https://doi.org//10.1007/s00381-016-3131-1 2016
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study https://doi.org/10.3390/cancers11101476 2019
Differential Expression of microRNAs in Medulloblastoma and the Potential Functional Consequences. https://doi.org/10.5137/1019-5149.JTN.19379-16.2 2017
A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy https://doi.org/10.1007/s00432-017-2478-3 2017